Introduction (English)
- New search for: Nakagawa, K.
- New search for: Nakagawa, K.
In:
ANNALS OF ONCOLOGY
;
23
;
xi5-xi5
;
2012
-
ISSN:
- Article (Journal) / Print
-
Title:Introduction
-
Contributors:Nakagawa, K. ( author )
-
Published in:ANNALS OF ONCOLOGY ; 23 ; xi5-xi5
-
Publisher:
- New search for: OXFORD UNIVERSITY PRESS
-
Publication date:2012-01-01
-
Size:xi5-xi5
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.992
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.992 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 23
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
Thanks to referees 2011| 2012
- 6
-
Dissecting responsive phenotypes through cytokine and angiogenic factor analysisRini, B. et al. | 2012
- 7
-
The hazards of randomized phase II trialsLara, P. N. / Redman, M. W. et al. | 2012
- 10
-
New treatment modalities in advanced thyroid cancerKapiteijn, E. / Schneider, T. C. / Morreau, H. / Gelderblom, H. / Nortier, J. W. / Smit, J. W. et al. | 2012
- 15
-
Palliative cancer care in Middle Eastern countries: accomplishments and challenges daggerSilbermann, M. / Arnaout, M. / Daher, M. / Nestoros, S. / Pitsillides, B. / Charalambous, H. / Gultekin, M. / Fahmi, R. / Mostafa, K. A. / Khleif, A. D. et al. | 2012
- 19
-
Sexual (dys)function and the quality of sexual life in patients with colorectal cancer: a systematic reviewTraa, M. J. / De Vries, J. / Roukema, J. A. / Den Oudsten, B. L. et al. | 2012
- 28
-
A meta-analysis on alcohol drinking and gastric cancer riskTramacere, I. / Negri, E. / Pelucchi, C. / Bagnardi, V. / Rota, M. / Scotti, L. / Islami, F. / Corrao, G. / La Vecchia, C. / Boffetta, P. et al. | 2012
- 29
-
Palliative communications: addressing chemotherapy in patients with advanced cancerKadakia, K. C. / Moynihan, T. J. / Smith, T. J. / Loprinzi, C. L. et al. | 2012
- 33
-
Patient-centered care: the key to cultural competenceEpner, D. E. / Baile, W. F. et al. | 2012
- 37
-
Dairy products and colorectal cancer risk: a systematic review and meta-analysis of cohort studiesAune, D. / Lau, R. / Chan, D. S. / Vieira, R. / Greenwood, D. C. / Kampman, E. / Norat, T. et al. | 2012
- 43
-
Palliative oncology: identity, progress, and the path aheadEpstein, A. S. / Morrison, R. S. et al. | 2012
- 46
-
A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinomaZurita, A. J. / Jonasch, E. / Wang, X. / Khajavi, M. / Yan, S. / Du, D. Z. / Xu, L. / Herynk, M. H. / McKee, K. S. / Tran, H. T. et al. | 2012
- 49
-
Spirituality in the cancer trajectoryPuchalski, C. M. et al. | 2012
- 53
-
A phase 2 study of patupilone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: Canadian Urologic Oncology Group study P07aChi, K. N. / Beardsley, E. / Eigl, B. J. / Venner, P. / Hotte, S. J. / Winquist, E. / Ko, Y. J. / Sridhar, S. S. / Weber, D. / Saad, F. et al. | 2012
- 56
-
Death and dying: what the patient wants daggerBalducci, L. et al. | 2012
- 59
-
2-18fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trialBachner, M. / Loriot, Y. / Gross-Goupil, M. / Zucali, P. A. / Horwich, A. / Germa-Lluch, J. R. / Kollmannsberger, C. / Stoiber, F. / Flechon, A. / Oechsle, K. et al. | 2012
- 62
-
Cultural diversity: family path through terminal illnessBaider, L. et al. | 2012
- 65
-
Clinically relevant fatigue in recurrence-free prostate cancer survivorsStorey, D. J. / McLaren, D. B. / Atkinson, M. A. / Butcher, I. / Liggatt, S. / O'Dea, R. / Smyth, J. F. / Sharpe, M. et al. | 2012
- 66
-
Cultural beliefs and values in cancer patientsDaher, M. et al. | 2012
- 70
-
Practical guidelines for developing new palliative care services: resource managementSmith, T. J. / Coyne, P. J. / Cassel, J. B. et al. | 2012
- 72
-
A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancerManegold, C. / van Zandwijk, N. / Szczesna, A. / Zatloukal, P. / Au, J. S. / Blasinska-Morawiec, M. / Serwatowski, P. / Krzakowski, M. / Jassem, J. / Tan, E. H. et al. | 2012
- 76
-
Turkish community-based palliative care model: a unique designOzgul, N. / Gultekin, M. / Koc, O. / Goksel, F. / Bayraktar, G. / Ekinci, H. / Sencan, I. / Tuncer, A. M. / Aksoy, M. / Tosun, N. et al. | 2012
- 78
-
The impact of phosphorylated AMP-activated protein kinase expression on lung cancer survivalWilliam, W. N. / Kim, J. S. / Liu, D. D. / Solis, L. / Behrens, C. / Lee, J. J. / Lippman, S. M. / Kim, E. S. / Hong, W. K. / Wistuba, I. I. et al. | 2012
- 79
-
Physicians prescribing habits for cancer pain in CyprusCharalambous, H. / Protopapa, E. / Gavrielidou, D. / Avgousti, V. et al. | 2012
- 86
-
Cross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trialsReiman, T. / Lai, R. / Veillard, A. S. / Paris, E. / Soria, J. C. / Rosell, R. / Taron, M. / Graziano, S. / Kratzke, R. / Seymour, L. et al. | 2012
- 93
-
Responses to subsequent anti-HER2 therapy after treatment with trastuzumab-DM1 in women with HER2-positive metastatic breast cancerOlson, E. M. / Lin, N. U. / DiPiro, P. J. / Najita, J. S. / Krop, I. E. / Winer, E. P. / Burstein, H. J. et al. | 2012
- 98
-
Do patients with invasive lobular breast cancer benefit in terms of adequate change in surgical therapy from a supplementary preoperative breast MRI?Heil, J. / Buehler, A. / Golatta, M. / Rom, J. / Schipp, A. / Harcos, A. / Schneeweiss, A. / Rauch, G. / Sohn, C. / Junkermann, H. et al. | 2012
- 104
-
Effect of protocol-related variables and womens characteristics on the cumulative false-positive risk in breast cancer screeningRoman, R. / Sala, M. / Salas, D. / Ascunce, N. / Zubizarreta, R. / Castells, X. et al. | 2012
- 111
-
First-line bevacizumab-containing therapy for breast cancer: results in patients aged ≥70 years treated in the ATHENA studyBiganzoli, L. / Di Vincenzo, E. / Jiang, Z. / Lichinitser, M. / Shen, Z. / Delva, R. / Bogdanova, N. / Vivanco, G. L. / Chen, Z. / Cheng, Y. et al. | 2012
- 119
-
A phase I study of sunitinib in combination with FOLFIRI in patients with untreated metastatic colorectal cancerStarling, N. / Vazquez-Mazon, F. / Cunningham, D. / Chau, I. / Tabernero, J. / Ramos, F. J. / Iveson, T. J. / Saunders, M. P. / Aranda, E. / Countouriotis, A. M. et al. | 2012
- 127
-
Pancreatic endocrine tumours: mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primariesCorbo, V. / Beghelli, S. / Bersani, S. / Antonello, D. / Talamini, G. / Brunelli, M. / Capelli, P. / Falconi, M. / Scarpa, A. et al. | 2012
- 135
-
Prognosis of mucinous histology for patients with radically resected stage II and III colon cancerCatalano, V. / Loupakis, F. / Graziano, F. / Bisonni, R. / Torresi, U. / Vincenzi, B. / Mari, D. / Giordani, P. / Alessandroni, P. / Salvatore, L. et al. | 2012
- 141
-
Chemoradiotherapy for anal cancer in HIV patients causes prolonged CD4 cell count suppressionAlfa-Wali, M. / Allen-Mersh, T. / Antoniou, A. / Tait, D. / Newsom-Davis, T. / Gazzard, B. / Nelson, M. / Bower, M. et al. | 2012
- 147
-
R-CHOEP-14 improves overall survival in young high-risk patients with diffuse large B-cell lymphoma compared with R-CHOP-14. A population-based investigation from the Danish Lymphoma GroupGang, A. O. / Strom, C. / Pedersen, M. / d'Amore, F. / Pedersen, L. M. / Bukh, A. / Pedersen, B. B. / Moeller, M. B. / Mortensen, L. S. / Gadeberg, O. V. et al. | 2012
- 153
-
Diabetes and non-Hodgkin's lymphoma: analyses of prevalence and annual incidence in 2005 using the National Health Insurance database in TaiwanTseng, C. H. et al. | 2012
- 159
-
Expert second-opinion pathology review of lymphoma in the era of the World Health Organization classificationMatasar, M. J. / Shi, W. / Silberstien, J. / Lin, O. / Busam, K. J. / Teruya-Feldstein, J. / Filippa, D. A. / Zelenetz, A. D. / Noy, A. et al. | 2012
- 166
-
Autologous stem-cell transplantation in patients with mantle cell lymphoma beyond 65 years of age: a study from the European Group for Blood and Marrow Transplantation (EBMT)Jantunen, E. / Canals, C. / Attal, M. / Thomson, K. / Milpied, N. / Buzyn, A. / Ferrant, A. / Biron, P. / Crawley, C. / Schattenberg, A. et al. | 2012
- 171
-
Diverging trends in incidence and mortality, and improved survival of non-Hodgkins lymphoma, in the Netherlands, 1989-2007van de Schans, S. A. / Issa, D. E. / Visser, O. / Nooijen, P. / Huijgens, P. C. / Karim-Kos, H. E. / Janssen-Heijnen, M. L. / Coebergh, J. W. et al. | 2012
- 182
-
Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG)Garbay, D. / Le Cesne, A. / Penel, N. / Chevreau, C. / Marec-Berard, P. / Blay, J. Y. / Debled, M. / Isambert, N. / Thyss, A. / Bompas, E. et al. | 2012
- 186
-
Association between dietary folate intake and clinical outcome in head and neck squamous cell carcinomaKawakita, D. / Matsuo, K. / Sato, F. / Oze, I. / Hosono, S. / Ito, H. / Watanabe, M. / Yatabe, Y. / Hanai, N. / Hasegawa, Y. et al. | 2012
- 193
-
Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experienceVandone, A. M. / Donadio, M. / Mozzati, M. / Ardine, M. / Polimeni, M. A. / Beatrice, S. / Ciuffreda, L. / Scoletta, M. et al. | 2012
- 200
-
Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trialDurand, J. P. / Deplanque, G. / Montheil, V. / Gornet, J. M. / Scotte, F. / Mir, O. / Cessot, A. / Coriat, R. / Raymond, E. / Mitry, E. et al. | 2012
- 205
-
Physician, patient and family attitudes regarding information on prognosis: a Brazilian surveyFumis, R. R. / De Camargo, B. / Del Giglio, A. et al. | 2012
- 211
-
Integrative oncology in the Middle East: from traditional herbal knowledge to contemporary cancer careBen-Arye, E. / Schiff, E. / Hassan, E. / Mutafoglu, K. / Lev-Ari, S. / Steiner, M. / Lavie, O. / Polliack, A. / Silbermann, M. / Lev, E. et al. | 2012
- 222
-
Impact of a novel nurse-led prechemotherapy education intervention (ChemoEd) on patient distress, symptom burden, and treatment-related information and support needs: results from a randomised, controlled trialAranda, S. / Jefford, M. / Yates, P. / Gough, K. / Seymour, J. / Francis, P. / Baravelli, C. / Breen, S. / Schofield, P. et al. | 2012
- 231
-
Phase Ib trial of radiotherapy in combination with combretastatin-A4-phosphate in patients with non-small-cell lung cancer, prostate adenocarcinoma, and squamous cell carcinoma of the head and neckNg, Q. S. / Mandeville, H. / Goh, V. / Alonzi, R. / Milner, J. / Carnell, D. / Meer, K. / Padhani, A. R. / Saunders, M. I. / Hoskin, P. J. et al. | 2012
- 238
-
Temsirolimus in combination with carboplatin and paclitaxel in patients with advanced solid tumors: a NCIC-CTG, phase I, open-label dose-escalation study (IND 179)Kollmannsberger, C. / Hirte, H. / Siu, L. L. / Mazurka, J. / Chi, K. / Elit, L. / Walsh, W. / Sederias, J. / Doyle, A. / Eisenhauer, E. A. et al. | 2012
- 245
-
Novel measurements of mammary stem cells in human umbilical cord blood as prospective predictors of breast cancer susceptibility in later lifeQiu, L. / Low, H. P. / Chang, C. I. / Strohsnitter, W. C. / Anderson, M. / Edmiston, K. / Adami, H. O. / Ekbom, A. / Hall, P. / Lagiou, P. et al. | 2012
- 251
-
Risk for incident and fatal prostate cancer in men with a family history of any incident and fatal cancerBrandt, A. / Sundquist, J. / Hemminki, K. et al. | 2012
- 256
-
Prostate cancer treatment ascertained from several sources: analysis of disagreement and errorGoodman, M. / Steenland, N. K. / Almon, M. L. / Liff, J. S. / Dilorio, C. K. / Butler, S. O. / Ekwueme, D. U. / Hall, I. J. / Smith, J. L. / Master, V. A. et al. | 2012
- 264
-
Fiber intake and pancreatic cancer risk: a case-control studyBidoli, E. / Pelucchi, C. / Zucchetto, A. / Negri, E. / Dal Maso, L. / Polesel, J. / Boz, G. / Montella, M. / Franceschi, S. / Serraino, D. et al. | 2012
- 269
-
Subsequent cancers in patients diagnosed with cancer of unknown primary (CUP): etiological insights?Shu, X. / Liu, H. / Ji, J. / Sundquist, K. / Forsti, A. / Sundquist, J. / Hemminki, K. et al. | 2012
- 276
-
Bevacizumab-induced laryngeal necrosisHartl, D. M. / Bahleda, R. / Hollebecque, A. / Bosq, J. / Massard, C. / Soria, J. C. et al. | 2012
- 278
-
Investigating changes over time in socioeconomic gaps in cancer survival: using differences in relative survival versus differences in excess mortality rates can give different answersBlakely, T. / Soeberg, M. / Sarfati, D. et al. | 2012
- 279
-
Reply to investigating changes over time in socioeconomic gaps in cancer survival: does choice of approach matter?Lyratzopoulos, G. / Rachet, B. / Coleman, M. P. et al. | 2012
- 280
-
Sorafenib-induced diarrhea and hypophosphatemia: mechanisms and therapeutic implicationsMir, O. / Coriat, R. / Boudou-Rouquette, P. / Durand, J. P. / Goldwasser, F. et al. | 2012
- 281
-
The ARCAD advanced colorectal cancer database-open for businessBuyse, M. / Sargent, D. J. / Goldberg, R. M. / de Gramont, A. et al. | 2012
- 283
-
Heine H. Hansen, 1938-2011: a European oncologistTonato, M. et al. | 2012
- 285
-
Screening mammography and socioeconomic inequalities in breast cancer survivalWoods, L. M. / Sasieni, P. / Rachet, B. et al. | 2012
- 287
-
A meta-analysis on alcohol drinking and esophageal and gastric cardia adenocarcinoma riskTramacere, I. / Pelucchi, C. / Bagnardi, V. / Rota, M. / Scotti, L. / Islami, F. / Corrao, G. / Boffetta, P. / La Vecchia, C. / Negri, E. et al. | 2012
- 298
-
Cancer of unknown primary: progress in the search for improved and rapid diagnosis leading toward superior patient outcomesGreco, F. A. / Oien, K. / Erlander, M. / Osborne, R. / Varadhachary, G. / Bridgewater, J. / Cohen, D. / Wasan, H. et al. | 2012
- 305
-
CMF revisited in the 21st centuryMunzone, E. / Curigliano, G. / Burstein, H. J. / Winer, E. P. / Goldhirsch, A. et al. | 2012
- 311
-
A meta-analysis of coffee consumption and pancreatic cancerTurati, F. / Galeone, C. / Edefonti, V. / Ferraroni, M. / Lagiou, P. / La Vecchia, C. / Tavani, A. et al. | 2012
- 319
-
Does an organised screening programme reduce the inequalities in breast cancer survival?Puliti, D. / Miccinesi, G. / Manneschi, G. / Buzzoni, C. / Crocetti, E. / Paci, E. / Zappa, M. et al. | 2012
- 324
-
Breast cancer subtypes and outcome after local and regional relapseMontagna, E. / Bagnardi, V. / Rotmensz, N. / Viale, G. / Renne, G. / Cancello, G. / Balduzzi, A. / Scarano, E. / Veronesi, P. / Luini, A. et al. | 2012
- 331
-
A phase II pilot trial incorporating bevacizumab into dose-dense doxorubicin and cyclophosphamide followed by paclitaxel in patients with lymph node positive breast cancer: a trial coordinated by the Eastern Cooperative Oncology GroupMiller, K. D. / O'Neill, A. / Perez, E. A. / Seidman, A. D. / Sledge, G. W. et al. | 2012
- 338
-
Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcomeYerushalmi, R. / Tyldesley, S. / Kennecke, H. / Speers, C. / Woods, R. / Knight, B. / Gelmon, K. A. et al. | 2012
- 346
-
Weekly paclitaxel as a single agent or in combination with carboplatin or weekly topotecan in patients with resistant ovarian cancer: the CARTAXHY randomized phase II trial from Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO)Lortholary, A. / Largillier, R. / Weber, B. / Gladieff, L. / Alexandre, J. / Durando, X. / Slama, B. / Dauba, J. / Paraiso, D. / Pujade-Lauraine, E. et al. | 2012
- 353
-
Prognostic value of KIT/PDGFRA mutations in gastrointestinal stromal tumours (GIST): Polish Clinical GIST Registry experienceWozniak, A. / Rutkowski, P. / Piskorz, A. / Ciwoniuk, M. / Osuch, C. / Bylina, E. / Sygut, J. / Chosia, M. / Rys, J. / Urbanczyk, K. et al. | 2012
- 361
-
External validation of nomogram for the prediction of recurrence after curative resection in early gastric cancerKim, J. H. / Kim, H. S. / Seo, W. Y. / Nam, C. M. / Kim, K. Y. / Jeung, H. C. / Lai, J. F. / Chung, H. C. / Noh, S. H. / Rha, S. Y. et al. | 2012
- 367
-
Small bowel adenocarcinoma copy number profiles are more closely related to colorectal than to gastric cancersHaan, J. C. / Buffart, T. E. / Eijk, P. P. / van de Wiel, M. A. / van Wieringen, W. N. / Howdle, P. D. / Mulder, C. J. / van de Velde, C. J. / Quirke, P. / Nagtegaal, I. D. et al. | 2012
- 374
-
Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4)Lucenteforte, E. / La Vecchia, C. / Silverman, D. / Petersen, G. M. / Bracci, P. M. / Ji, B. T. / Bosetti, C. / Li, D. / Gallinger, S. / Miller, A. B. et al. | 2012
- 382
-
Lung cancer physicians' referral practices for palliative care consultationSmith, C. B. / Nelson, J. E. / Berman, A. R. / Powell, C. A. / Fleischman, J. / Salazar-Schicchi, J. / Wisnivesky, J. P. et al. | 2012
- 388
-
Survival benefit with erlotinib maintenance therapy in patients with advanced non-small-cell lung cancer (NSCLC) according to response to first-line chemotherapyCoudert, B. / Ciuleanu, T. / Park, K. / Wu, Y. L. / Giaccone, G. / Brugger, W. / Gopalakrishna, P. / Cappuzzo, F. et al. | 2012
- 395
-
Sunitinib followed by sorafenib or vice versa for metastatic renal cell carcinoma-data from the Czech registryBuchler, T. / Klapka, R. / Melichar, B. / Brabec, P. / Dusek, L. / Vyzula, R. / Abrahamova, J. et al. | 2012
- 401
-
The hOGG1 mutant genotype is associated with prostate cancer susceptibility and aggressive clinicopathological characteristics in the Korean populationYun, S. J. / Ha, Y. S. / Chae, Y. / Kim, J. S. / Kim, I. Y. / Kim, W. J. et al. | 2012
- 406
-
Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinomaGalsky, M. D. / Chen, G. J. / Oh, W. K. / Bellmunt, J. / Roth, B. J. / Petrioli, R. / Dogliotti, L. / Dreicer, R. / Sonpavde, G. et al. | 2012
- 411
-
Risk of second cancers in Waldenstrom macroglobulinemiaVarettoni, M. / Tedeschi, A. / Arcaini, L. / Pascutto, C. / Vismara, E. / Orlandi, E. / Ricci, F. / Corso, A. / Greco, A. / Mangiacavalli, S. et al. | 2012
- 415
-
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphomaZinzani, P. L. / Tani, M. / Pulsoni, A. / De Renzo, A. / Stefoni, V. / Broccoli, A. / Montini, G. C. / Fina, M. / Pellegrini, C. / Gandolfi, L. et al. | 2012
- 421
-
Risk of hepatitis B reactivation and the role of novel agents and stem-cell transplantation in multiple myeloma patients with hepatitis B virus (HBV) infectionMya, D. H. / Han, S. T. / Linn, Y. C. / Hwang, W. Y. / Goh, Y. T. / Tan, D. C. et al. | 2012
- 427
-
Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluationFountzilas, G. / Ciuleanu, E. / Bobos, M. / Kalogera-Fountzila, A. / Eleftheraki, A. G. / Karayannopoulou, G. / Zaramboukas, T. / Nikolaou, A. / Markou, K. / Resiga, L. et al. | 2012
- 435
-
T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical resultsSecondino, S. / Zecca, M. / Licitra, L. / Gurrado, A. / Schiavetto, I. / Bossi, P. / Locati, L. / Schiavo, R. / Basso, S. / Baldanti, F. et al. | 2012
- 442
-
Clinical outcome of patients with various advanced cancer types vaccinated with an optimized cryptic human telomerase reverse transcriptase (TERT) peptide: results of an expanded phase II studyKotsakis, A. / Vetsika, E. K. / Christou, S. / Hatzidaki, D. / Vardakis, N. / Aggouraki, D. / Konsolakis, G. / Georgoulias, V. / Christophyllakis, C. / Cordopatis, P. et al. | 2012
- 450
-
Immunogenicity and safety of the influenza A H1N1v 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE studyRousseau, B. / Loulergue, P. / Mir, O. / Krivine, A. / Kotti, S. / Viel, E. / Simon, T. / de Gramont, A. / Goldwasser, F. / Launay, O. et al. | 2012
- 458
-
Intracranial hemorrhage in patients with cancer treated with bevacizumab: the Memorial Sloan-Kettering experienceKhasraw, M. / Holodny, A. / Goldlust, S. A. / DeAngelis, L. M. et al. | 2012
- 463
-
Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumorsSoria, J. C. / Cortes, J. / Massard, C. / Armand, J. P. / De Andreis, D. / Ropert, S. / Lopez, E. / Catteau, A. / James, J. / Marier, J. F. et al. | 2012
- 472
-
Survival from common and rare cancers in Germany in the early 21st centuryHiripi, E. / Gondos, A. / Emrich, K. / Holleczek, B. / Katalinic, A. / Luttmann, S. / Sirri, E. / Brenner, H. et al. | 2012
- 479
-
Association between body mass index and the colorectal cancer risk in Japan: pooled analysis of population-based cohort studies in JapanMatsuo, K. / Mizoue, T. / Tanaka, K. / Tsuji, I. / Sugawara, Y. / Sasazuki, S. / Nagata, C. / Tamakoshi, A. / Wakai, K. / Inoue, M. et al. | 2012
- 491
-
Dietary cholesterol intake and cancerHu, J. / La Vecchia, C. / de Groh, M. / Negri, E. / Morrison, H. / Mery, L. et al. | 2012
- 501
-
Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer NetworkStacchiotti, S. / Palassini, E. / Sanfilippo, R. / Vincenzi, B. / Arena, M. G. / Bochicchio, A. M. / De Rosa, P. / Nuzzo, A. / Turano, S. / Morosi, C. et al. | 2012
- 508
-
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group studyGrignani, G. / Palmerini, E. / Dileo, P. / Asaftei, S. D. / D'Ambrosio, L. / Pignochino, Y. / Mercuri, M. / Picci, P. / Fagioli, F. / Casali, P. G. et al. | 2012
- 517
-
Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcomePenel, N. / Italiano, A. / Ray-Coquard, I. / Chaigneau, L. / Delcambre, C. / Robin, Y. M. / Bui, B. / Bertucci, F. / Isambert, N. / Cupissol, D. et al. | 2012
- 524
-
Trends of cutaneous melanoma in The Netherlands: increasing incidence rates among all Breslow thickness categories and rising mortality rates since 1989Hollestein, L. M. / van den Akker, S. A. / Nijsten, T. / Karim-Kos, H. E. / Coebergh, J. W. / de Vries, E. et al. | 2012
- 531
-
First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07)von Moos, R. / Seifert, B. / Simcock, M. / Goldinger, S. M. / Gillessen, S. / Ochsenbein, A. / Michielin, O. / Cathomas, R. / Schlappi, M. / Moch, H. et al. | 2012
- 537
-
Toxicity burden score: a novel approach to summarize multiple toxic effectsLee, S. M. / Hershman, D. L. / Martin, P. / Leonard, J. P. / Cheung, Y. K. et al. | 2012
- 542
-
Second malignancies among Waldenstrom macroglobulinemia patients: small samples and sparse dataOjha, R. P. / Thertulien, R. et al. | 2012
- 543
-
"The only thing I know is that I know nothing": 5-fluorouracil in human milkPeccatori, F. A. / Giovannetti, E. / Pistilli, B. / Bellettini, G. / Codacci-Pisanelli, G. / Losekoot, N. / Curigliano, G. / Azim, H. A. / Goldhirsch, A. / Peters, G. J. et al. | 2012
- 545
-
Pulmonary nodules in patients with melanoma-assume nothingMurphy, F. / Gleeson, F. V. / Middleton, M. R. et al. | 2012
- 547
-
Cytotoxic drugs for patients with breast cancer in the era of targeted treatment: back to the future?Ribeiro, J. T. / Macedo, L. T. / Curigliano, G. / Fumagalli, L. / Locatelli, M. / Dalton, M. / Quintela, A. / Carvalheira, J. B. / Manunta, S. / Mazzarella, L. et al. | 2012
- 556
-
Trabectedin plus pegylated liposomal doxorubicin in the treatment of patients with partially platinum-sensitive ovarian cancer: current evidence and future perspectivesSehouli, J. / Alfaro, V. / Gonzalez-Martin, A. et al. | 2012
- 562
-
Update on desmoid tumorsEscobar, C. / Munker, R. / Thomas, J. O. / Li, B. D. / Burton, G. V. et al. | 2012
- 570
-
New strategies and designs in pancreatic cancer research: consensus guidelines report from a European expert paneldaggerVan Laethem, J. L. / Verslype, C. / Iovanna, J. L. / Michl, P. / Conroy, T. / Louvet, C. / Hammel, P. / Mitry, E. / Ducreux, M. / Maraculla, T. et al. | 2012
- 577
-
Histology and outcomes of newly detected lung lesions in melanoma patientsSmyth, E. C. / Hsu, M. / Panageas, K. S. / Chapman, P. B. et al. | 2012
- 582
-
Locoregional recurrence risk after lipofilling in breast cancer patientsPetit, J. Y. / Botteri, E. / Lohsiriwat, V. / Rietjens, M. / De Lorenzi, F. / Garusi, C. / Rossetto, F. / Martella, S. / Manconi, A. / Bertolini, F. et al. | 2012
- 589
-
Randomized phase II non-inferiority study (NO16853) of two different doses of capecitabine in combination with docetaxel for locally advanced/metastatic breast cancerBuzdar, A. U. / Xu, B. / Digumarti, R. / Goedhals, L. / Hu, X. / Semiglazov, V. / Cheporov, S. / Gotovkin, E. / Hoersch, S. / Rittweger, K. et al. | 2012
- 597
-
Zoledronic acid blocks the interaction between mesenchymal stem cells and breast cancer cells: implications for adjuvant therapy of breast cancerGallo, M. / De Luca, A. / Lamura, L. / Normanno, N. et al. | 2012
- 604
-
Death causes in breast cancer patientsRiihimaki, M. / Thomsen, H. / Brandt, A. / Sundquist, J. / Hemminki, K. et al. | 2012
- 610
-
Phase II study of single-agent bosutinib, a Src/Abl tyrosine kinase inhibitor, in patients with locally advanced or metastatic breast cancer pretreated with chemotherapyCampone, M. / Bondarenko, I. / Brincat, S. / Hotko, Y. / Munster, P. N. / Chmielowska, E. / Fumoleau, P. / Ward, R. / Bardy-Bouxin, N. / Leip, E. et al. | 2012
- 618
-
High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patientsPierga, J. Y. / Hajage, D. / Bachelot, T. / Delaloge, S. / Brain, E. / Campone, M. / Dieras, V. / Rolland, E. / Mignot, L. / Mathiot, C. et al. | 2012
- 625
-
Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancerAlbanell, J. / Gonzalez, A. / Ruiz-Borrego, M. / Alba, E. / Garcia-Saenz, J. A. / Corominas, J. M. / Burgues, O. / Furio, V. / Rojo, A. / Palacios, J. et al. | 2012
- 632
-
Paclitaxel efficacy and toxicity in older women with metastatic breast cancer: combined analysis of CALGB 9342 and 9840Lichtman, S. M. / Hurria, A. / Cirrincione, C. T. / Seidman, A. D. / Winer, E. / Hudis, C. / Cohen, H. J. / Muss, H. B. et al. | 2012
- 638
-
Sam68 expression and cytoplasmic localization is correlated with lymph node metastasis as well as prognosis in patients with early-stage cervical cancerLi, Z. / Yu, C. P. / Zhong, Y. / Liu, T. J. / Huang, Q. D. / Zhao, X. H. / Huang, H. / Tu, H. / Jiang, S. / Zhang, Y. et al. | 2012
- 647
-
Intraoperative hyperthermic versus postoperative normothermic intraperitoneal chemotherapy for colonic peritoneal carcinomatosis: a case-control studyCashin, P. H. / Graf, W. / Nygren, P. / Mahteme, H. et al. | 2012
- 652
-
Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendixLieu, C. H. / Lambert, L. A. / Wolff, R. A. / Eng, C. / Zhang, N. / Wen, S. / Rafeeq, S. / Taggart, M. / Fournier, K. / Royal, R. et al. | 2012
- 659
-
Genetic polymorphism of IGF-I predicts recurrence in patients with gastric cancer who have undergone curative gastrectomyShitara, K. / Ito, S. / Misawa, K. / Ito, Y. / Ito, H. / Hosono, S. / Watanabe, M. / Tajima, K. / Tanaka, H. / Muro, K. et al. | 2012
- 664
-
Phase II trial of preoperative chemoradiotherapy with oxaliplatin, cisplatin, and 5-FU in locally advanced esophageal and gastric cancerPera, M. / Gallego, R. / Montagut, C. / Martin-Richard, M. / Iglesias, M. / Conill, C. / Reig, A. / Balague, C. / Petriz, L. / Momblan, D. et al. | 2012
- 670
-
Correlation of cytidine deaminase polymorphisms and activity with clinical outcome in gemcitabine-/platinum-treated advanced non-small-cell lung cancer patientsTibaldi, C. / Giovannetti, E. / Tiseo, M. / Leon, L. G. / DIncecco, A. / Loosekoot, N. / Bartolotti, M. / Honeywell, R. / Cappuzzo, F. / Ardizzoni, A. et al. | 2012
- 678
-
Phase II trial of PTK787/ZK 222584 (vatalanib) administered orally once-daily or in two divided daily doses as second-line monotherapy in relapsed or progressing patients with stage IIIB/IV non-small-cell lung cancer (NSCLC)Gauler, T. C. / Besse, B. / Mauguen, A. / Meric, J. B. / Gounant, V. / Fischer, B. / Overbeck, T. R. / Krissel, H. / Laurent, D. / Tiainen, M. et al. | 2012
- 688
-
Sunitinib in combination with docetaxel and prednisone in chemotherapy-naive patients with metastatic, castration-resistant prostate cancer: a phase 1/2 clinical trialDaggerZurita, A. J. / George, D. J. / Shore, N. D. / Liu, G. / Wilding, G. / Hutson, T. E. / Kozloff, M. / Mathew, P. / Harmon, C. S. / Wang, S. L. et al. | 2012
- 695
-
Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trialCognetti, F. / Ruggeri, E. M. / Felici, A. / Gallucci, M. / Muto, G. / Pollera, C. F. / Massidda, B. / Rubagotti, A. / Giannarelli, D. / Boccardo, F. et al. | 2012
- 701
-
Costs of early adjuvant radiation therapy after radical prostatectomy: a decision analysisShowalter, T. N. / Foley, K. A. / Jutkowitz, E. / Lallas, C. D. / Trabulsi, E. J. / Gomella, L. G. / Dicker, A. P. / Pizzi, L. T. et al. | 2012
- 707
-
Genetic polymorphisms in androgen receptor-binding sites predict survival in prostate cancer patients receiving androgen-deprivation therapyHuang, C. N. / Huang, S. P. / Pao, J. B. / Chang, T. Y. / Lan, Y. H. / Lu, T. L. / Lee, H. Z. / Juang, S. H. / Wu, P. P. / Pu, Y. S. et al. | 2012
- 714
-
Could thyroid dysfunction influence outcome in sunitinib-treated metastatic renal cell carcinoma?Sabatier, R. / Eymard, J. C. / Walz, J. / Deville, J. L. / Narbonne, H. / Boher, J. M. / Salem, N. / Marcy, M. / Brunelle, S. / Viens, P. et al. | 2012
- 722
-
The International Scoring System (ISS) for multiple myeloma remains a robust prognostic tool independently of patients' renal functionDimopoulos, M. A. / Kastritis, E. / Michalis, E. / Tsatalas, C. / Michael, M. / Pouli, A. / Kartasis, Z. / Delimpasi, S. / Gika, D. / Zomas, A. et al. | 2012
- 729
-
Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletionMian, M. / Scandurra, M. / Chigrinova, E. / Shen, Y. / Inghirami, G. / Greiner, T. C. / Chan, W. C. / Vose, J. M. / Testoni, M. / Chiappella, A. et al. | 2012
- 736
-
Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkins lymphomaAzambuja, D. / Natkunam, Y. / Biasoli, I. / Lossos, I. S. / Anderson, M. W. / Morais, J. C. / Spector, N. et al. | 2012
- 743
-
Prospective evaluation of corrected QT intervals and arrhythmias after exposure to epirubicin, cyclophosphamide, and 5-fluorouracil in women with breast cancerKitagawa, K. / Kawada, K. / Morita, S. / Inada, M. / Mitsuma, A. / Sawaki, M. / Iino, S. / Inden, Y. / Murohara, T. / Imai, T. et al. | 2012
- 748
-
Chemotherapy dose reductions in obese patients with colorectal cancerChambers, P. / Daniels, S. H. / Thompson, L. C. / Stephens, R. J. et al. | 2012
- 754
-
Association of body mass index in early adulthood and middle age with future site-specific cancer mortality: the Harvard Alumni Health StudyGray, L. / Lee, I. M. / Sesso, H. D. / Batty, G. D. et al. | 2012
- 760
-
Power and limits of modern cancer diagnostics: cancer of unknown primaryHemminki, K. / Liu, H. / Heminki, A. / Sundquist, J. et al. | 2012
- 765
-
Dietary patterns and the risk of esophageal cancerBravi, F. / Edefonti, V. / Randi, G. / Garavello, W. / La Vecchia, C. / Ferraroni, M. / Talamini, R. / Franceschi, S. / Decarli, A. et al. | 2012
- 771
-
Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcomaGronchi, A. / Bui, B. N. / Bonvalot, S. / Pilotti, S. / Ferrari, S. / Hohenberger, P. / Hohl, R. J. / Demetri, G. D. / Le Cesne, A. / Lardelli, P. et al. | 2012
- 777
-
High-dose chemotherapy consolidation for chemosensitive advanced soft tissue sarcoma patients: an open-label, randomized controlled trialBui-Nguyen, B. / Ray-Coquard, I. / Chevreau, C. / Penel, N. / Bay, J. O. / Coindre, J. M. / Cupissol, D. / Italiano, A. / Bonichon, F. / Lotz, J. P. et al. | 2012
- 785
-
Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: the Axtell regimenVerschraegen, C. F. / Arias-Pulido, H. / Lee, S. J. / Movva, S. / Cerilli, L. A. / Eberhardt, S. / Schmit, B. / Quinn, R. / Muller, C. Y. / Rabinowitz, I. et al. | 2012
- 791
-
Pooled analysis of cardiac safety in patients with cancer treated with pertuzumabLenihan, D. / Suter, T. / Brammer, M. / Neate, C. / Ross, G. / Baselga, J. et al. | 2012
- 801
-
Bringing geriatrics into oncology or also oncology into geriatrics?Monfardini, S. / Giordano, G. / Sandri, R. / Gnocchi, P. L. / Galetti, G. et al. | 2012
- 801
-
Aprepitant quetiapine: a clinically significant drug interaction in a patient treated for head and neck cancerVerwimp-Hoeks, M. P. / van Herpen, C. M. / Burger, D. M. et al. | 2012
- 802
-
About locoregional recurrence risk after lipofilling in breast cancer patientsSemprini, G. / Cattin, F. / Lazzaro, L. / Cedolini, C. / Parodi, P. C. et al. | 2012
- 803
-
Reply to about locoregional recurrence risk after lipofilling in breast cancer patientsPetit, J. Y. / Lohsiriwat, V. / Rietjens, M. et al. | 2012
- 804
-
Clinical activity of sorafenib in patients with advanced gastrointestinal stromal tumor bearing PDGFRA exon 18 mutation: a case seriesRoubaud, G. / Kind, M. / Coindre, J. M. / Maki, R. G. / Bui, B. / Italiano, A. et al. | 2012
- 805
-
Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma)Zinzani, P. L. / Derenzini, E. / Pellegrini, C. / Rigacci, L. / Fabbri, A. / Gandolfi, L. / Argnani, L. / Casadei, B. / Pulsoni, A. / Gobbi, M. et al. | 2012
- 807
-
Reply to Rituxan is not associated with Stevens-Johnson syndromeParise, L. / Kahle, J. / Schlaak, M. / Mauch, C. / Kurschat, P. et al. | 2012
- 807
-
Objective response to sorafenib in advanced clear-cell sarcomaMir, O. / Boudou-Rouquette, P. / Larousserie, F. / Babinet, A. / Dumaine, V. / Anract, P. / Goldwasser, F. et al. | 2012
- 810
-
errata| 2012
- 813
-
Salvage or savage chemotherapy for poor-risk or relapsed testis cancer-20 years later, not much has changedRaghavan, D. et al. | 2012
- 815
-
Intensified chemotherapy with stem-cell rescue in germ-cell tumorsSimonelli, M. / Rosti, G. / Banna, G. L. / Pedrazzoli, P. et al. | 2012
- 823
-
Diagnosis of invasive fungal infections in hematology and oncology-guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO)Ruhnke, M. / Bohme, A. / Buchheidt, D. / Cornely, O. / Donhuijsen, K. / Einsele, H. / Enzensberger, R. / Hebart, H. / Heussel, C. P. / Horger, M. et al. | 2012
- 834
-
Imaging bone metastases in breast cancer: evidence on comparative test accuracyHoussami, N. / Costelloe, C. M. et al. | 2012
- 843
-
Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studiesAune, D. / Greenwood, D. C. / Chan, D. S. / Vieira, R. / Vieira, A. R. / Navarro Rosenblatt, D. A. / Cade, J. E. / Burley, V. J. / Norat, T. et al. | 2012
- 853
-
Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countriesSaini, K. S. / Taylor, C. / Ramirez, A. J. / Palmieri, C. / Gunnarsson, U. / Schmoll, H. J. / Dolci, S. M. / Ghenne, C. / Metzger-Filho, O. / Skrzypski, M. et al. | 2012
- 860
-
A metabolic phenotyping approach to understanding relationships between metabolic syndrome and breast tumour responses to chemotherapyStebbing, J. / Sharma, A. / North, B. / Athersuch, T. J. / Zebrowski, A. / Pchejetski, D. / Coombes, R. C. / Nicholson, J. K. / Keun, H. C. et al. | 2012
- 866
-
Does trauma or an intercurrent surgical intervention lead to a short-term increase in breast cancer recurrence rates?Allawi, Z. / Cuzick, J. / Baum, M. et al. | 2012
- 870
-
Identifying factors that impact survival among women with inflammatory breast cancerDawood, S. / Ueno, N. T. / Valero, V. / Woodward, W. A. / Buchholz, T. A. / Hortobagyi, G. N. / Gonzalez-Angulo, A. M. / Cristofanilli, M. et al. | 2012
- 876
-
Is breast-conserving therapy a safe option for patients with tumor multicentricity and multifocality?Yerushalmi, R. / Tyldesley, S. / Woods, R. / Kennecke, H. F. / Speers, C. / Gelmon, K. A. et al. | 2012
- 882
-
Adjuvant endocrine therapy with tamoxifen in young women with breast cancer: determinants of interruptions vary over timeCluze, C. / Rey, D. / Huiart, L. / BenDiane, M. K. / Bouhnik, A. D. / Berenger, C. / Carrieri, M. P. / Giorgi, R. et al. | 2012
- 891
-
Recurrence risk score based on the specific activity of CDK1 and CDK2 predicts response to neoadjuvant paclitaxel followed by 5-fluorouracil, epirubicin and cyclophosphamide in breast cancersKim, S. J. / Nakayama, S. / Shimazu, K. / Tamaki, Y. / Akazawa, K. / Tsukamoto, F. / Torikoshi, Y. / Matsushima, T. / Shibayama, M. / Ishihara, H. et al. | 2012
- 897
-
Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factorsSerrano, C. / Cortes, J. / De Mattos-Arruda, L. / Bellet, M. / Gomez, P. / Saura, C. / Perez, J. / Vidal, M. / Munoz-Couselo, E. / Carreras, M. J. et al. | 2012
- 903
-
Laparoscopic versus open radical hysterectomy in early-stage cervical cancer: long-term survival outcomes in a matched cohort studyNam, J. H. / Park, J. Y. / Kim, D. Y. / Kim, J. H. / Kim, Y. M. / Kim, Y. T. et al. | 2012
- 911
-
Adjuvant capecitabine chemotherapy using a tailored-dose strategy in elderly patients with colon cancerChang, H. J. / Lee, K. W. / Kim, J. H. / Bang, S. M. / Kim, Y. J. / Kim, D. W. / Kang, S. B. / Lee, J. S. et al. | 2012
- 919
-
Clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumabdaggerMalka, D. / Boige, V. / Jacques, N. / Vimond, N. / Adenis, A. / Boucher, E. / Pierga, J. Y. / Conroy, T. / Chauffert, B. / Francois, E. et al. | 2012
- 927
-
Autoimmune disease and subsequent digestive tract cancer by histologyHemminki, K. / Liu, X. / Ji, J. / Sundquist, J. / Sundquist, K. et al. | 2012
- 933
-
Cediranib in combination with mFOLFOX6 in Japanese patients with metastatic colorectal cancer: results from the randomised phase II part of a phase I/II studyKato, T. / Muro, K. / Yamaguchi, K. / Bando, H. / Hazama, S. / Amagai, K. / Baba, H. / Denda, T. / Shi, X. / Fukase, K. et al. | 2012
- 942
-
A dose escalation study of gemcitabine plus oxaliplatin in combination with imatinib for gemcitabine-refractory advanced pancreatic adenocarcinomaStarling, N. / Hawkes, E. A. / Chau, I. / Watkins, D. / Thomas, J. / Webb, J. / Brown, G. / Thomas, K. / Barbachano, Y. / Oates, J. et al. | 2012
- 948
-
The initial change in tumor size predicts response and survival in patients with metastatic colorectal cancer treated with combination chemotherapySuzuki, C. / Blomqvist, L. / Sundin, A. / Jacobsson, H. / Bystrom, P. / Berglund, A. / Nygren, P. / Glimelius, B. et al. | 2012
- 954
-
Treatment and survival of patients with small-cell lung cancer: small steps forward, but not for patients >80Janssen-Heijnen, M. L. / Maas, H. A. / Siesling, S. / Koning, C. C. / Coebergh, J. W. / Groen, H. J. et al. | 2012
- 961
-
The influence of platinum pathway polymorphisms on the outcome in patients with malignant mesotheliomaErculj, N. / Kovac, V. / Hmeljak, J. / Dolzan, V. et al. | 2012
- 968
-
A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancerTolcher, A. W. / Quinn, D. I. / Ferrari, A. / Ahmann, F. / Giaccone, G. / Drake, T. / Keating, A. / de Bono, J. S. et al. | 2012
- 973
-
Distribution of metastatic sites in renal cell carcinoma: a population-based analysisBianchi, M. / Sun, M. / Jeldres, C. / Shariat, S. F. / Trinh, Q. D. / Briganti, A. / Tian, Z. / Schmitges, J. / Graefen, M. / Perrotte, P. et al. | 2012
- 981
-
The polymorphisms in the VHL and HIF1A genes are associated with the prognosis but not the development of renal cell carcinomaQin, C. / Cao, Q. / Ju, X. / Wang, M. / Meng, X. / Zhu, J. / Yan, F. / Li, P. / Ding, Q. / Chen, J. et al. | 2012
- 990
-
Induction therapy of AML with ara-C plus daunorubicin versus ara-C plus gemtuzumab ozogamicin: a randomized phase II trial in elderly patientsBrunnberg, U. / Mohr, M. / Noppeney, R. / Durk, H. A. / Sauerland, M. C. / Muller-Tidow, C. / Krug, U. / Koschmieder, S. / Kessler, T. / Mesters, R. M. et al. | 2012
- 997
-
A phase II study evaluating the safety and efficacy of an adenovirus-DLMP1-LMP2 transduced dendritic cell vaccine in patients with advanced metastatic nasopharyngeal carcinomaChia, W. K. / Wang, W. W. / Teo, M. / Tai, W. M. / Lim, W. T. / Tan, E. H. / Leong, S. S. / Sun, L. / Chen, J. J. / Gottschalk, S. et al. | 2012
- 1005
-
Erlotinib and chemoradiation in patients with surgically resected locally advanced squamous cell carcinoma of the head and neck: a GICOR phase I trialArias de la Vega, F. / Contreras, J. / de las Heras, M. / de la Torre, A. / Arrazubi, V. / Herruzo, I. / Prieto, I. / Garcia-Saenz, J. A. / Romero, J. / Calvo, F. A. et al. | 2012
- 1010
-
Gefitinib, cisplatin, and concurrent radiotherapy for locally advanced head and neck cancer: EGFR FISH, protein expression, and mutational status are not predictive biomarkersTan, E. H. / Goh, C. / Lim, W. T. / Soo, K. C. / Khoo, M. L. / Tan, T. / Tan, D. S. / Ang, M. K. / Ng, Q. S. / Tan, P. H. et al. | 2012
- 1016
-
Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neckHitt, R. / Irigoyen, A. / Cortes-Funes, H. / Grau, J. J. / Garcia-Saenz, J. A. / Cruz-Hernandez, J. J. et al. | 2012
- 1023
-
Phase I study of continuous and intermittent schedules of lapatinib in combination with vinorelbine in solid tumorsChew, H. K. / Somlo, G. / Mack, P. C. / Gitlitz, B. / Gandour-Edwards, R. / Christensen, S. / Linden, H. / Solis, L. J. / Yang, X. / Davies, A. M. et al. | 2012
- 1030
-
Vascular and pharmacokinetic effects of EndoTAG-1 in patients with advanced cancer and liver metastasisFasol, U. / Frost, A. / Buchert, M. / Arends, J. / Fiedler, U. / Scharr, D. / Scheuenpflug, J. / Mross, K. et al. | 2012
- 1037
-
Phase I study of the effects of renal impairment on the pharmacokinetics and safety of satraplatin in patients with refractory solid tumorsGalsky, M. D. / Camacho, L. H. / Chiorean, E. G. / Mulkerin, D. / Hong, D. S. / Oh, W. K. / Bajorin, D. F. et al. | 2012
- 1044
-
European cancer mortality predictions for the year 2012Malvezzi, M. / Bertuccio, P. / Levi, F. / La Vecchia, C. / Negri, E. et al. | 2012
- 1053
-
Role of medical history and medication use in the aetiology of upper aerodigestive tract cancers in Europe: the ARCAGE studyMacfarlane, T. V. / Macfarlane, G. J. / Thakker, N. S. / Benhamou, S. / Bouchardy, C. / Ahrens, W. / Pohlabeln, H. / Lagiou, P. / Lagiou, A. / Castellsague, X. et al. | 2012
- 1061
-
Inverse association between soy intake and non-Hodgkin lymphoma risk among women: a case-control study in JapanChihara, D. / Matsuo, K. / Kanda, J. / Hosono, S. / Ito, H. / Nakamura, S. / Seto, M. / Morishima, Y. / Tajima, K. / Tanaka, H. et al. | 2012
- 1067
-
Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomasGronchi, A. / Miceli, R. / Colombo, C. / Stacchiotti, S. / Collini, P. / Mariani, L. / Sangalli, C. / Radaelli, S. / Sanfilippo, R. / Fiore, M. et al. | 2012
- 1074
-
Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized studyJouary, T. / Leyral, C. / Dreno, B. / Doussau, A. / Sassolas, B. / Beylot-Barry, M. / Renaud-Vilmer, C. / Guillot, B. / Bernard, P. / Lok, C. et al. | 2012
- 1081
-
A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptorCampanati, A. / Berardi, R. / Onofri, A. / Pierantoni, C. / Conte, I. / Giuliodori, K. / Molinelli, E. / Marcucci, F. / Cascinu, S. / Offidani, A. et al. | 2012
- 1083
-
DNA ploidy in endometrial cancer: unfinished business?Terada, K. et al. | 2012
- 1085
-
Recent developments in treatments targeting castration-resistant prostate cancer bone metastasesLoriot, Y. / Massard, C. / Fizazi, K. et al. | 2012
- 1095
-
Esophageal carcinoma advances in treatment results for locally advanced disease: reviewHerskovic, A. / Russell, W. / Liptay, M. / Fidler, M. J. / Al-Sarraf, M. et al. | 2012
- 1104
-
Preferences for cancer treatments: an overview of methods and applications in oncologyBlinman, P. / King, M. / Norman, R. / Viney, R. / Stockler, M. R. et al. | 2012
- 1111
-
Predicting and managing the risk of pulmonary haemorrhage in patients with NSCLC treated with bevacizumab: a consensus report from a panel of expertsReck, M. / Barlesi, F. / Crino, L. / Henschke, C. I. / Isla, D. / Stiebeler, S. / Spigel, D. R. et al. | 2012
- 1121
-
A multicenter phase III prospective randomized trial of high-dose epirubicin in combination with cyclophosphamide (EC) versus docetaxel followed by EC in node-positive breast cancer. GOIM (Gruppo Oncologico Italia Meridionale) 9902 studyVici, P. / Brandi, M. / Giotta, F. / Foggi, P. / Schittulli, F. / Di Lauro, L. / Gebbia, N. / Massidda, B. / Filippelli, G. / Giannarelli, D. et al. | 2012
- 1130
-
Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysisCortes, J. / Calvo, V. / Ramirez-Merino, N. / OShaughnessy, J. / Brufsky, A. / Robert, N. / Vidal, M. / Munoz, E. / Perez, J. / Dawood, S. et al. | 2012
- 1138
-
Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trialEjlertsen, B. / Aldridge, J. / Nielsen, K. V. / Regan, M. M. / Henriksen, K. L. / Lykkesfeldt, A. E. / Muller, S. / Gelber, R. D. / Price, K. N. / Rasmussen, B. B. et al. | 2012
- 1144
-
Circulating tumor cells in immunohistochemical subtypes of metastatic breast cancer: lack of prediction in HER2-positive disease treated with targeted therapyGiordano, A. / Giuliano, M. / De Laurentiis, M. / Arpino, G. / Jackson, S. / Handy, B. C. / Ueno, N. T. / Andreopoulou, E. / Alvarez, R. H. / Valero, V. et al. | 2012
- 1151
-
High prevalence of vertebral fractures in women with breast cancer starting aromatase inhibitor therapyBouvard, B. / Hoppe, E. / Soulie, P. / Georgin-Mege, M. / Jadaud, E. / Abadie-Lacourtoisie, S. / Petit Le Manac'h, A. / Laffitte, A. / Levasseur, R. / Audran, M. et al. | 2012
- 1156
-
Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancerRojo, F. / Garcia-Parra, J. / Zazo, S. / Tusquets, I. / Ferrer-Lozano, J. / Menendez, S. / Eroles, P. / Chamizo, C. / Servitja, S. / Ramirez-Merino, N. et al. | 2012
- 1164
-
A multicenter randomized phase III trial of vinorelbine/gemcitabine doublet versus capecitabine monotherapy in anthracycline- and taxane-pretreated women with metastatic breast cancerPallis, A. G. / Boukovinas, I. / Ardavanis, A. / Varthalitis, I. / Malamos, N. / Georgoulias, V. / Mavroudis, D. et al. | 2012
- 1170
-
Cost comparison of axillary sentinel lymph node detection and axillary lymphadenectomy in early breast cancer. A national study based on a prospective multi-institutional series of 985 patients `on behalf of the Group of Surgeons from the French Unicancer Federation'Classe, J. M. / Baffert, S. / Sigal-Zafrani, B. / Fall, M. / Rousseau, C. / Alran, S. / Rouanet, P. / Belichard, C. / Mignotte, H. / Ferron, G. et al. | 2012
- 1178
-
Prognostic importance of DNA ploidy and DNA index in stage I and II endometrioid adenocarcinoma of the endometriumPradhan, M. / Abeler, V. M. / Danielsen, H. E. / Sandstad, B. / Trope, C. G. / Kristensen, G. B. / Risberg, B. A. et al. | 2012
- 1185
-
Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trialGladieff, L. / Ferrero, A. / De Rauglaudre, G. / Brown, C. / Vasey, P. / Reinthaller, A. / Pujade-Lauraine, E. / Reed, N. / Lorusso, D. / Siena, S. et al. | 2012
- 1190
-
Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacyTwelves, C. / Scheithauer, W. / McKendrick, J. / Seitz, J. F. / Van Hazel, G. / Wong, A. / Diaz-Rubio, E. / Gilberg, F. / Cassidy, J. et al. | 2012
- 1198
-
Prognostic value of preoperative radiological staging assessed by computed tomography in patients with nonmetastatic colon cancerHuh, J. W. / Jeong, Y. Y. / Kim, H. R. / Kim, Y. J. et al. | 2012
- 1207
-
An EZH2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patientsCrea, F. / Fornaro, L. / Paolicchi, E. / Masi, G. / Frumento, P. / Loupakis, F. / Salvatore, L. / Cremolini, C. / Schirripa, M. / Graziano, F. et al. | 2012
- 1214
-
Cationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer: a randomized controlled phase II trialLohr, J. M. / Haas, S. L. / Bechstein, W. O. / Bodoky, G. / Cwiertka, K. / Fischbach, W. / Folsch, U. R. / Jager, D. / Osinsky, D. / Prausova, J. et al. | 2012
- 1223
-
Third CECOG consensus on the systemic treatment of non-small-cell lung cancerBrodowicz, T. / Ciuleanu, T. / Crawford, J. / Filipits, M. / Fischer, J. R. / Georgoulias, V. / Gridelli, C. / Hirsch, F. R. / Jassem, J. / Kosmidis, P. et al. | 2012
- 1229
-
The eligibility of advanced non-small-cell lung cancer patients for targeted therapy clinical trialsClarey, J. / Kao, S. C. / Clarke, S. J. / Vardy, J. et al. | 2012
- 1234
-
Multicenter phase II study of trabectedin in patients with metastatic castration-resistant prostate cancerMichaelson, M. D. / Bellmunt, J. / Hudes, G. R. / Goel, S. / Lee, R. J. / Kantoff, P. W. / Stein, C. A. / Lardelli, P. / Pardos, I. / Kahatt, C. et al. | 2012
- 1241
-
Phase II study of eribulin mesylate (E7389) in patients with metastatic castration-resistant prostate cancer stratified by prior taxane therapyde Bono, J. S. / Molife, L. R. / Sonpavde, G. / Maroto, J. P. / Calvo, E. / Cartwright, T. H. / Loesch, D. M. / Feit, K. / Das, A. / Zang, E. A. et al. | 2012
- 1250
-
Optimal prostate-specific antigen screening interval for prostate cancerKobayashi, D. / Takahashi, O. / Fukui, T. / Glasziou, P. P. et al. | 2012
- 1254
-
Two escalated followed by six standard BEACOPP in advanced-stage high-risk classical Hodgkin lymphoma: high cure rates but increased risk of aseptic osteonecrosisFossa, A. / Fiskvik, I. H. / Kolstad, A. / Lauritzsen, G. F. / Aurlien, E. / Blystad, A. K. / Hole, K. H. / Ikonomou, I. M. / Holte, H. et al. | 2012
- 1259
-
Minimising critical organ irradiation in limited stage Hodgkin lymphoma: a dosimetric study of the benefit of involved node radiotherapyCampbell, B. A. / Hornby, C. / Cunninghame, J. / Burns, M. / MacManus, M. / Ryan, G. / Lau, E. / Seymour, J. F. / Wirth, A. et al. | 2012
- 1267
-
CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study GroupSchmitz, N. / Zeynalova, S. / Glass, B. / Kaiser, U. / Cavallin-Stahl, E. / Wolf, M. / Haenel, M. / Loeffler, M. / Truemper, L. / Pfreundschuh, M. et al. | 2012
- 1274
-
Clinical relevance of flow cytometric immunophenotyping of the cerebrospinal fluid in patients with diffuse large B-cell lymphomaAlvarez, R. / Dupuis, J. / Plonquet, A. / Christov, C. / Copie-Bergman, C. / Hemery, F. / Gaillard, I. / El Gnaoui, T. / Kuhnowski, F. / Bedoui, M. et al. | 2012
- 1280
-
Two sides of the medallion: poor treatment tolerance but better survival by standard chemotherapy in elderly patients with advanced-stage diffuse large B-cell lymphomavan de Schans, S. A. / Wymenga, A. N. / van Spronsen, D. J. / Schouten, H. C. / Coebergh, J. W. / Janssen-Heijnen, M. L. et al. | 2012
- 1287
-
A phase II study of concurrent cetuximab-cisplatin and intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinomaMa, B. B. / Kam, M. K. / Leung, S. F. / Hui, E. P. / King, A. D. / Chan, S. L. / Mo, F. / Loong, H. / Yu, B. K. / Ahuja, A. et al. | 2012
- 1293
-
Multidisciplinary team working across different tumour types: analysis of a national surveyLamb, B. W. / Sevdalis, N. / Taylor, C. / Vincent, C. / Green, J. S. et al. | 2012
- 1301
-
Sequential research-related biopsies in phase I trials: acceptance, feasibility and safetyGomez-Roca, C. A. / Lacroix, L. / Massard, C. / De Baere, T. / Deschamps, F. / Pramod, R. / Bahleda, R. / Deutsch, E. / Bourgier, C. / Angevin, E. et al. | 2012
- 1307
-
A phase I dose escalation study of AT9283, a small molecule inhibitor of aurora kinases, in patients with advanced solid malignanciesArkenau, H. T. / Plummer, R. / Molife, L. R. / Olmos, D. / Yap, T. A. / Squires, M. / Lewis, S. / Lock, V. / Yule, M. / Lyons, J. et al. | 2012
- 1314
-
An intra-patient placebo-controlled phase I trial to evaluate the safety and tolerability of intradermal IMM-101 in melanomaStebbing, J. / Dalgleish, A. / Gifford-Moore, A. / Martin, A. / Gleeson, C. / Wilson, G. / Brunet, L. R. / Grange, J. / Mudan, S. et al. | 2012
- 1320
-
Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC projectGonzalez, C. A. / Megraud, F. / Buissonniere, A. / Lujan Barroso, L. / Agudo, A. / Duell, E. J. / Boutron-Ruault, M. C. / Clavel-Chapelon, F. / Palli, D. / Krogh, V. et al. | 2012
- 1325
-
Changes in incidence, survival and mortality of prostate cancer in Europe and the United States in the PSA era: additional diagnoses and avoided deathsNeppl-Huber, C. / Zappa, M. / Coebergh, J. W. / Rapiti, E. / Rachtan, J. / Holleczek, B. / Rosso, S. / Aareleid, T. / Brenner, H. / Gondos, A. et al. | 2012
- 1335
-
A nonrandom association of gastrointestinal stromal tumor (GIST) and desmoid tumor (deep fibromatosis): case series of 28 patientsDumont, A. G. / Rink, L. / Godwin, A. K. / Miettinen, M. / Joensuu, H. / Strosberg, J. R. / Gronchi, A. / Corless, C. L. / Goldstein, D. / Rubin, B. P. et al. | 2012
- 1341
-
Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastasesSaad, F. / Brown, J. E. / Van Poznak, C. / Ibrahim, T. / Stemmer, S. M. / Stopeck, A. T. / Diel, I. J. / Takahashi, S. / Shore, N. / Henry, D. H. et al. | 2012
- 1348
-
Celecoxib can prevent capecitabine-related hand-foot syndrome in stage II and III colorectal cancer patients: result of a single-center, prospective randomized phase III trialZhang, R. X. / Wu, X. J. / Wan, D. S. / Lu, Z. H. / Kong, L. H. / Pan, Z. Z. / Chen, G. et al. | 2012
- 1353
-
Acupuncture compared with placebo acupuncture in radiotherapy-induced nausea-a randomized controlled studyEnblom, A. / Johnsson, A. / Hammar, M. / Onelov, E. / Steineck, G. / Borjeson, S. et al. | 2012
- 1362
-
Attributable causes of cancer in Japan in 2005-systematic assessment to estimate current burden of cancer attributable to known preventable risk factors in JapanInoue, M. / Sawada, N. / Matsuda, T. / Iwasaki, M. / Sasazuki, S. / Shimazu, T. / Shibuya, K. / Tsugane, S. et al. | 2012
- 1370
-
EZH2 polymorphism and benefit from bevacizumab in colorectal cancer: another piece to the puzzleFornaro, L. / Crea, F. / Masi, G. / Paolicchi, E. / Loupakis, F. / Graziano, F. / Salvatore, L. / Ronzoni, M. / Ricci, V. / Cremolini, C. et al. | 2012
- 1371
-
HER2-negative (1+) breast cancer with unfavorable prognostic features: to FISH or not to FISH?Iorfida, M. / Dellapasqua, S. / Bagnardi, V. / Cardillo, A. / Rotmensz, N. / Mastropasqua, M. G. / Bottiglieri, L. / Goldhirsch, A. / Viale, G. / Colleoni, M. et al. | 2012
- 1373
-
Predicting and accounting for VTE in phase I cancer studiesKhorana, A. A. et al. | 2012
- 1375
-
Endocrine-responsive breast cancer special types: who cares?Bonnefoi, H. / MacGrogan, G. et al. | 2012
- 1378
-
The sequential use of endocrine treatment for advanced breast cancer: where are we?Barrios, C. / Forbes, J. F. / Jonat, W. / Conte, P. / Gradishar, W. / Buzdar, A. / Gelmon, K. / Gnant, M. / Bonneterre, J. / Toi, M. et al. | 2012
- 1387
-
Vaccination therapy for non-small-cell lung cancer: review of agents in phase III developmentDecoster, L. / Wauters, I. / Vansteenkiste, J. F. et al. | 2012
- 1394
-
Dietary fiber and breast cancer risk: a systematic review and meta-analysis of prospective studiesAune, D. / Chan, D. S. / Greenwood, D. C. / Vieira, A. R. / Rosenblatt, D. A. / Vieira, R. / Norat, T. et al. | 2012
- 1403
-
Aspirin and cancer risk: a quantitative review to 2011Bosetti, C. / Rosato, V. / Gallus, S. / Cuzick, J. / La Vecchia, C. et al. | 2012
- 1416
-
Incidence, risk factors and clinical implications of venous thromboembolism in cancer patients treated within the context of phase I studies: the `SENDO experience'Mandala, M. / Clerici, M. / Corradino, I. / Vitalini, C. / Colombini, S. / Torri, V. / De Pascale, A. / Marsoni, S. et al. | 2012
- 1422
-
Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) StudyPsyrri, A. / Kalogeras, K. T. / Kronenwett, R. / Wirtz, R. M. / Batistatou, A. / Bournakis, E. / Timotheadou, E. / Gogas, H. / Aravantinos, G. / Christodoulou, C. et al. | 2012
- 1428
-
Outcome of special types of luminal breast cancerColleoni, M. / Rotmensz, N. / Maisonneuve, P. / Mastropasqua, M. G. / Luini, A. / Veronesi, P. / Intra, M. / Montagna, E. / Cancello, G. / Cardillo, A. et al. | 2012
- 1436
-
Retreatment with trastuzumab-based therapy after disease progression following lapatinib in HER2-positive metastatic breast cancerGori, S. / Montemurro, F. / Spazzapan, S. / Metro, G. / Foglietta, J. / Bisagni, G. / Ferzi, A. / Silva, R. R. / Gamucci, T. / Clavarezza, M. et al. | 2012
- 1441
-
A phase II study of eribulin in Japanese patients with heavily pretreated metastatic breast cancerAogi, K. / Iwata, H. / Masuda, N. / Mukai, H. / Yoshida, M. / Rai, Y. / Taguchi, K. / Sasaki, Y. / Takashima, S. et al. | 2012
- 1449
-
Stellate ganglion block for the management of hot flashes and sleep disturbances in breast cancer survivors: an uncontrolled experimental study with 24 weeks of follow-upHaest, K. / Kumar, A. / Van Calster, B. / Leunen, K. / Smeets, A. / Amant, F. / Berteloot, P. / Wildiers, H. / Paridaens, R. / Van Limbergen, E. et al. | 2012
- 1455
-
The Cyclin D1 (CCND1) A870G polymorphism predicts clinical outcome to lapatinib and capecitabine in HER2-positive metastatic breast cancerLaBonte, M. J. / Wilson, P. M. / Yang, D. / Zhang, W. / Ladner, R. D. / Ning, Y. / Gerger, A. / Bohanes, P. O. / Benhaim, L. / El-khoueiry, R. et al. | 2012
- 1465
-
Long-term (37 years) clinical outcome of older women with early operable primary breast cancer managed in a dedicated clinicSyed, B. M. / Johnston, S. J. / Wong, D. W. / Green, A. R. / Winterbottom, L. / Kennedy, H. / Simpson, N. / Morgan, D. A. / Ellis, I. O. / Cheung, K. L. et al. | 2012
- 1471
-
Retrospective review of male breast cancer patients: analysis of tamoxifen-related side-effectsPemmaraju, N. / Munsell, M. F. / Hortobagyi, G. N. / Giordano, S. H. et al. | 2012
- 1474
-
Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen, or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21/07)Zaman, K. / Thurlimann, B. / Huober, J. / Schonenberger, A. / Pagani, O. / Luthi, J. / Simcock, M. / Giobbie-Hurder, A. / Berthod, G. / Genton, C. et al. | 2012
- 1481
-
Borderline ovarian tumors diagnosed during pregnancy exhibit a high incidence of aggressive features: results of a French multicenter studyFauvet, R. / Brzakowski, M. / Morice, P. / Resch, B. / Marret, H. / Graesslin, O. / Darai, E. et al. | 2012
- 1488
-
Proanthocyanidins and other flavonoids in relation to pancreatic cancer: a case-control study in ItalyRossi, M. / Lugo, A. / Lagiou, P. / Zucchetto, A. / Polesel, J. / Serraino, D. / Negri, E. / Trichopoulos, D. / La Vecchia, C. et al. | 2012
- 1494
-
Importance of gender in diffuse malignant peritoneal mesotheliomaCao, C. / Yan, T. D. / Deraco, M. / Elias, D. / Glehen, O. / Levine, E. A. / Moran, B. J. / Morris, D. L. / Chua, T. C. / Piso, P. et al. | 2012
- 1499
-
Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working PartyDArena, G. / Valentini, C. G. / Pietrantuono, G. / Guariglia, R. / Martorelli, M. C. / Mansueto, G. / Villani, O. / Onofrillo, D. / Falcone, A. / Specchia, G. et al. | 2012
- 1503
-
Comparison of toxicity profiles of fluorouracil versus oxaliplatin regimens in a large population-based cohort of elderly patients with colorectal cancerCen, P. / Liu, C. / Du, X. L. et al. | 2012
- 1512
-
Perioperative docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophageal and gastric adenocarcinoma: a multicenter phase II trialFerri, L. E. / Ades, S. / Alcindor, T. / Chasen, M. / Marcus, V. / Hickeson, M. / Artho, G. / Thirlwell, M. P. et al. | 2012
- 1518
-
PIK3CA exon 20 mutations as a potential biomarker for resistance to anti-EGFR monoclonal antibodies in KRAS wild-type metastatic colorectal cancer: a systematic review and meta-analysisMao, C. / Yang, Z. Y. / Hu, X. F. / Chen, Q. / Tang, J. L. et al. | 2012
- 1525
-
Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II studyMarechal, R. / Vos, B. / Polus, M. / Delaunoit, T. / Peeters, M. / Demetter, P. / Hendlisz, A. / Demols, A. / Franchimont, D. / Verset, G. et al. | 2012
- 1531
-
Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of Capecitabine, Bevacizumab and Mitomycin CPrice, T. J. / Zannino, D. / Wilson, K. / Simes, R. J. / Cassidy, J. / Van Hazel, G. A. / Robinson, B. A. / Broad, A. / Ganju, V. / Ackland, S. P. et al. | 2012
- 1537
-
Postprogression survival for first-line chemotherapy of patients with advanced non-small-cell lung cancerHayashi, H. / Okamoto, I. / Morita, S. / Taguri, M. / Nakagawa, K. et al. | 2012
- 1542
-
Clinically relevant fatigue in men with hormone-sensitive prostate cancer on long-term androgen deprivation therapyStorey, D. J. / McLaren, D. B. / Atkinson, M. A. / Butcher, I. / Frew, L. C. / Smyth, J. F. / Sharpe, M. et al. | 2012
- 1549
-
Primary anti-vascular endothelial growth factor (VEGF)-refractory metastatic renal cell carcinoma: clinical characteristics, risk factors, and subsequent therapyHeng, D. Y. / MacKenzie, M. J. / Vaishampayan, U. N. / Bjarnason, G. A. / Knox, J. J. / Tan, M. H. / Wood, L. / Wang, Y. / Kollmannsberger, C. / North, S. et al. | 2012
- 1555
-
Combination of rituximab, bortezomib, doxorubicin, dexamethasone and chlorambucil (RiPAD+C) as first-line therapy for elderly mantle cell lymphoma patients: results of a phase II trial from the GOELAMSHouot, R. / Le Gouill, S. / Ojeda Uribe, M. / Mounier, C. / Courby, S. / Dartigeas, C. / Bouabdallah, K. / Alexis Vigier, M. / Moles, M. P. / Tournilhac, O. et al. | 2012
- 1562
-
A phase II study of sunitinib in recurrent and/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: current progress and challenges in evaluating molecularly targeted agents in ACCChau, N. G. / Hotte, S. J. / Chen, E. X. / Chin, S. F. / Turner, S. / Wang, L. / Siu, L. L. et al. | 2012
- 1571
-
Prevalence and predictors of complementary and alternative medicine (CAM) use by men in Australian cancer outpatient servicesKlafke, N. / Eliott, J. A. / Wittert, G. A. / Olver, I. N. et al. | 2012
- 1579
-
Internet use by cancer patients: should oncologists `prescribe' accurate web sites in combination with chemotherapy? A survey in a Spanish cohortLopez-Gomez, M. / Ortega, C. / Suarez, I. / Serralta, G. / Madero, R. / Gomez-Raposo, C. / Sereno, M. / Casado, E. / Espinosa, E. / Lobo, F. et al. | 2012
- 1586
-
Alcohol drinking and bladder cancer risk: a meta-analysisPelucchi, C. / Galeone, C. / Tramacere, I. / Bagnardi, V. / Negri, E. / Islami, F. / Scotti, L. / Bellocco, R. / Corrao, G. / Boffetta, P. et al. | 2012
- 1593
-
Large body size and sedentary lifestyle during childhood and early adulthood and esophageal squamous cell carcinoma in a high-risk populationEtemadi, A. / Golozar, A. / Kamangar, F. / Freedman, N. D. / Shakeri, R. / Matthews, C. / Islami, F. / Boffetta, P. / Brennan, P. / Abnet, C. C. et al. | 2012
- 1601
-
Advanced well-differentiated/dedifferentiated liposarcomas: role of chemotherapy and survivalItaliano, A. / Toulmonde, M. / Cioffi, A. / Penel, N. / Isambert, N. / Bompas, E. / Duffaud, F. / Patrikidou, A. / Lortal, B. / Le Cesne, A. et al. | 2012
- 1607
-
Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trialsWhelan, J. S. / Jinks, R. C. / McTiernan, A. / Sydes, M. R. / Hook, J. M. / Trani, L. / Uscinska, B. / Bramwell, V. / Lewis, I. J. / Nooij, M. A. et al. | 2012
- 1617
-
Restoration of chemosensitivity for doxorubicin and cisplatin in chondrosarcoma in vitro: BCL-2 family members cause chemoresistancevan Oosterwijk, J. G. / Herpers, B. / Meijer, D. / Briaire-de Bruijn, I. H. / Cleton-Jansen, A. M. / Gelderblom, H. / van de Water, B. / Bovee, J. V. et al. | 2012
- 1626
-
Endocrine late sequelae in long-term survivors of childhood non-Hodgkin lymphomavan Waas, M. / Neggers, S. J. / te Winkel, M. L. / Beishuizen, A. / Pieters, R. / van den Heuvel-Eibrink, M. M. et al. | 2012
- 1633
-
Heterogeneity among lists of cautioned or prohibited drugs in protocols of early-phase oncology trialsYou, B. / Pond, G. / Siu, L. L. / Nagai, J. / Cheiken, R. / Chen, E. et al. | 2012
- 1640
-
A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndromeVadhan-Raj, S. / Fayad, L. E. / Fanale, M. A. / Pro, B. / Rodriguez, A. / Hagemeister, F. B. / Bueso-Ramos, C. E. / Zhou, X. / McLaughlin, P. W. / Fowler, N. et al. | 2012
- 1646
-
Randomized controlled trials in the era of molecular oncology: methodology, biomarkers, and end pointsKay, A. / Higgins, J. / Day, A. G. / Meyer, R. M. / Booth, C. M. et al. | 2012
- 1653
-
Liquid biopsy to test new treatment strategies in breast cancer: are we there yet?Ignatiadis, M. / Piccart, M. et al. | 2012
- 1655
-
X-ACT: An important step on an unfinished journeyMaughan, T. et al. | 2012
- 1659
-
Imatinib rechallenge in patients with advanced gastrointestinal stromal tumorsBlay, J. Y. / Perol, D. / Le Cesne, A. et al. | 2012
- 1665
-
Body mass index and incidence of localized and advanced prostate cancer-a dose-response meta-analysis of prospective studiesDiscacciati, A. / Orsini, N. / Wolk, A. et al. | 2012
- 1672
-
Risk of venous and arterial thromboembolic events associated with anti-EGFR agents: a meta-analysis of randomized clinical trialsPetrelli, F. / Cabiddu, M. / Borgonovo, K. / Barni, S. et al. | 2012
- 1680
-
Phase III study of nilotinib versus best supportive care with or without a TKI in patients with gastrointestinal stromal tumors resistant to or intolerant of imatinib and sunitinibReichardt, P. / Blay, J. Y. / Gelderblom, H. / Schlemmer, M. / Demetri, G. D. / Bui-Nguyen, B. / McArthur, G. A. / Yazji, S. / Hsu, Y. / Galetic, I. et al. | 2012
- 1687
-
Serial FDG-PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapyHendlisz, A. / Golfinopoulos, V. / Garcia, C. / Covas, A. / Emonts, P. / Ameye, L. / Paesmans, M. / Deleporte, A. / Machiels, G. / Toussaint, E. et al. | 2012
- 1693
-
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer-subgroup analysis of patients with KRAS: mutated tumours in the randomised German AIO study KRK-0306Stintzing, S. / Fischer von Weikersthal, L. / Decker, T. / Vehling-Kaiser, U. / Jager, E. / Heintges, T. / Stoll, C. / Giessen, C. / Modest, D. P. / Neumann, J. et al. | 2012
- 1699
-
The validation of matrix metalloproteinase-9 mRNA gene expression as a predictor of outcome in patients with metastatic gastric cancerAl-Batran, S. E. / Pauligk, C. / Wirtz, R. / Werner, D. / Steinmetz, K. / Homann, N. / Schmalenberg, H. / Hofheinz, R. D. / Hartmann, J. T. / Atmaca, A. et al. | 2012
- 1706
-
Analysis of HER-3, insulin growth factor-1, nuclear factor-kB and epidermal growth factor receptor gene copy number in the prediction of clinical outcome for K-RAS wild-type colorectal cancer patients receiving irinotecan-cetuximabScartozzi, M. / Giampieri, R. / Maccaroni, E. / Mandolesi, A. / Giustini, L. / Silva, R. / Zaniboni, A. / Biscotti, T. / Biagetti, S. / Galizia, E. et al. | 2012
- 1713
-
The prognostic and predictive value of serum CA19.9 in pancreatic cancerHumphris, J. L. / Chang, D. K. / Johns, A. L. / Scarlett, C. J. / Pajic, M. / Jones, M. D. / Colvin, E. K. / Nagrial, A. / Chin, V. T. / Chantrill, L. A. et al. | 2012
- 1723
-
Biomarker analysis in a phase III study of pemetrexed-carboplatin versus etoposide-carboplatin in chemonaive patients with extensive-stage small-cell lung cancerSmit, E. F. / Socinski, M. A. / Mullaney, B. P. / Myrand, S. P. / Scagliotti, G. V. / Lorigan, P. / Reck, M. / Ciuleanu, T. / von Pawel, J. / Karaseva, N. A. et al. | 2012
- 1730
-
Updated survival and outcomes for older adults with inoperable stage III non-small-cell lung cancer treated with cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel: analysis of a phase III trial from the Hoosier Oncology Group (HOG) and US OncologyJalal, S. I. / Riggs, H. D. / Melnyk, A. / Richards, D. / Agarwala, A. / Neubauer, M. / Ansari, R. / Govindan, R. / Bruetman, D. / Fisher, W. et al. | 2012
- 1738
-
Immunohistochemistry to identify EGFR mutations or ALK rearrangements in patients with lung adenocarcinomaHofman, P. / Ilie, M. / Hofman, V. / Roux, S. / Valent, A. / Bernheim, A. / Alifano, M. / Leroy-Ladurie, F. / Vaylet, F. / Rouquette, I. et al. | 2012
- 1744
-
Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II studyGeorgoulias, V. / Bozionelou, V. / Agelaki, S. / Perraki, M. / Apostolaki, S. / Kallergi, G. / Kalbakis, K. / Xyrafas, A. / Mavroudis, D. et al. | 2012
- 1750
-
Glutathione S-transferase P1 c.313A > G polymorphism could be useful in the prediction of doxorubicin response in breast cancer patientsRomero, A. / Martin, M. / Oliva, B. / de la Torre, J. / Furio, V. / de la Hoya, M. / Garcia-Saenz, J. A. / Moreno, A. / Roman, J. M. / Diaz-Rubio, E. et al. | 2012
- 1756
-
An observational study of the prevalence and incidence of comorbid conditions in older women with breast cancerDanese, M. D. / OMalley, C. / Lindquist, K. / Gleeson, M. / Griffiths, R. I. et al. | 2012
- 1766
-
Validation of a predictive model that identifies patients at high risk of developing febrile neutropaenia following chemotherapy for breast cancerJenkins, P. / Scaife, J. / Freeman, S. et al. | 2012
- 1771
-
Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancerHe, X. / Esteva, F. J. / Ensor, J. / Hortobagyi, G. N. / Lee, M. H. / Yeung, S. C. et al. | 2012
- 1780
-
Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: a randomized phase II trialRayson, D. / Suter, T. M. / Jackisch, C. / van der Vegt, S. / Bermejo, B. / van den Bosch, J. / Vivanco, G. L. / van Gent, A. M. / Wildiers, H. / Torres, A. et al. | 2012
- 1788
-
Trastuzumab induces antibody-dependent cell-mediated cytotoxicity (ADCC) in HER-2-non-amplified breast cancer cell linesCollins, D. M. / ODonovan, N. / McGowan, P. M. / OSullivan, F. / Duffy, M. J. / Crown, J. et al. | 2012
- 1795
-
Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF-kB activationBondong, S. / Kiefel, H. / Hielscher, T. / Zeimet, A. G. / Zeillinger, R. / Pils, D. / Schuster, E. / Castillo-Tong, D. C. / Cadron, I. / Vergote, I. et al. | 2012
- 1803
-
Randomized phase II trial of docetaxel plus prednisone in combination with placebo or AT-101, an oral small molecule Bcl-2 family antagonist, as first-line therapy for metastatic castration-resistant prostate cancerSonpavde, G. / Matveev, V. / Burke, J. M. / Caton, J. R. / Fleming, M. T. / Hutson, T. E. / Galsky, M. D. / Berry, W. R. / Karlov, P. / Holmlund, J. T. et al. | 2012
- 1809
-
Long-term follow-up of high-dose chemotherapy with autologous stem-cell transplantation and response-adapted whole-brain radiotherapy for newly diagnosed primary CNS lymphoma: results of the multicenter Ostdeutsche Studiengruppe Hamatologie und Onkologie OSHO-53 phase II studyKiefer, T. / Hirt, C. / Spath, C. / Schuler, F. / Al-Ali, H. K. / Wolf, H. H. / Herbst, R. / Maschmeyer, G. / Helke, K. / Kessler, C. et al. | 2012
- 1813
-
Lung malignancies after Hodgkin lymphoma: disease characteristics, detection methods and clinical outcomeSchoenfeld, J. D. / Mauch, P. M. / Das, P. / Silver, B. / Marcus, K. J. / Stevenson, M. A. / Ng, A. K. et al. | 2012
- 1818
-
Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trialBehringer, K. / Thielen, I. / Mueller, H. / Goergen, H. / Eibl, A. D. / Rosenbrock, J. / Halbsguth, T. / Eichenauer, D. A. / Fuchs, M. / Reiners, K. S. et al. | 2012
- 1825
-
Adding docetaxel to cisplatin and fluorouracil in patients with unresectable head and neck cancer: a cost-utility analysisLiberato, N. L. / Rognoni, C. / Rubrichi, S. / Quaglini, S. / Marchetti, M. / Gorlia, T. / Licitra, L. / Vermorken, J. B. et al. | 2012
- 1832
-
Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation studyGranata, R. / Miceli, R. / Orlandi, E. / Perrone, F. / Cortelazzi, B. / Franceschini, M. / Locati, L. D. / Bossi, P. / Bergamini, C. / Mirabile, A. et al. | 2012
- 1838
-
Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents: results from a historic cohortBarba, M. / Sperati, F. / Stranges, S. / Carlomagno, C. / Nasti, G. / Iaffaioli, V. / Caolo, G. / Mottolese, M. / Botti, G. / Terrenato, I. et al. | 2012
- 1845
-
Evaluation of glomerular filtration rate estimation by Cockcroft-Gault, Jelliffe, Wright and Modification of Diet in Renal Disease (MDRD) formulae in oncology patientsAinsworth, N. L. / Marshall, A. / Hatcher, H. / Whitehead, L. / Whitfield, G. A. / Earl, H. M. et al. | 2012
- 1854
-
Survival in cancer of unknown primary site: population-based analysis by site and histologyHemminki, K. / Bevier, M. / Hemminki, A. / Sundquist, J. et al. | 2012
- 1864
-
Relationship between LAPTM4B gene polymorphism and susceptibility of primary liver cancerWang, S. / Zhang, Q. Y. / Zhou, R. L. et al. | 2012
- 1869
-
Nutrient-based dietary patterns and the risk of head and neck cancer: a pooled analysis in the International Head and Neck Cancer Epidemiology consortiumEdefonti, V. / Hashibe, M. / Ambrogi, F. / Parpinel, M. / Bravi, F. / Talamini, R. / Levi, F. / Yu, G. / Morgenstern, H. / Kelsey, K. et al. | 2012
- 1880
-
Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4)Bosetti, C. / Lucenteforte, E. / Silverman, D. T. / Petersen, G. / Bracci, P. M. / Ji, B. T. / Negri, E. / Li, D. / Risch, H. A. / Olson, S. H. et al. | 2012
- 1889
-
Epidemiology, management and economic impact of febrile neutropenia in oncology patients receiving routine care at a regional UK cancer centreSchelenz, S. / Giles, D. / Abdallah, S. et al. | 2012
- 1894
-
Body mass, tobacco smoking, alcohol drinking and risk of cancer of the small intestine-a pooled analysis of over 500 000 subjects in the Asia Cohort ConsortiumBoffetta, P. / Hazelton, W. D. / Chen, Y. / Sinha, R. / Inoue, M. / Gao, Y. T. / Koh, W. P. / Shu, X. O. / Grant, E. J. / Tsuji, I. et al. | 2012
- 1899
-
153Samarium-EDTMP administration followed by hematopoietic stem cell support for bone metastases in osteosarcoma patientsBerger, M. / Grignani, G. / Giostra, A. / Ferrari, S. / Ferraresi, V. / Tamburini, A. / Cefalo, G. / Carnevale-Schianca, F. / Vassallo, E. / Picci, P. et al. | 2012
- 1906
-
High-quality care for all children with cancerKnops, R. R. / Hulscher, M. E. / Hermens, R. P. / Hilbink-Smolders, M. / Loeffen, J. L. / Kollen, W. J. / Kaspers, G. J. / Caron, H. N. / Kremer, L. C. et al. | 2012
- 1912
-
Impact of a cancer clinical trials web site on discussions about trial participation: a cluster randomized trialDear, R. F. / Barratt, A. L. / Askie, L. M. / Butow, P. N. / McGeechan, K. / Crossing, S. / Currow, D. C. / Tattersall, M. H. et al. | 2012
- 1919
-
Phase II open-label study of erlotinib in combination with gemcitabine in unresectable and/or metastatic adenocarcinoma of the pancreas: relationship between skin rash and survival (Pantar study)Aranda, E. / Manzano, J. L. / Rivera, F. / Galan, M. / Valladares-Ayerbes, M. / Pericay, C. / Safont, M. J. / Mendez, M. J. / Irigoyen, A. / Arrivi, A. et al. | 2012
- 1926
-
Hepatitis B virus infection adds lymphoma burden in KoreaHuh, J. / Suh, C. et al. | 2012
- 1926
-
Reply to the letter to the editor on hepatitis B virus infection adds lymphoma burden in KoreaShin, A. / Shin, H. R. et al. | 2012
- 1928
-
Implications of the new histological classification (WHO 2010) for pancreatic neuroendocrine neoplasmsCrippa, S. / Partelli, S. / Boninsegna, L. / Falconi, M. et al. | 2012
- 1929
-
IMPAKT Breast Cancer Conference| 2012
- 1931
-
Annals of Oncology: a statement of editorial intentVermorken, J. B. et al. | 2012
- 1932
-
Supportive care and palliative care: a time for unity in diversityAapro, M. S. et al. | 2012
- 1934
-
Learning from toxicity patterns in phase I trials during the era of mechanism targeted agentsGreystoke, A. / Ranson, M. et al. | 2012
- 1937
-
Oxaliplatin-related thrombocytopeniaJardim, D. L. / Rodrigues, C. A. / Novis, Y. A. / Rocha, V. G. / Hoff, P. M. et al. | 2012
- 1943
-
Incidence and management of mTOR inhibitor-associated pneumonitis in patients with metastatic renal cell carcinomaAlbiges, L. / Chammings, F. / Duclos, B. / Stern, M. / Motzer, R. J. / Ravaud, A. / Camus, P. et al. | 2012
- 1954
-
Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. ironAapro, M. / Osterborg, A. / Gascon, P. / Ludwig, H. / Beguin, Y. et al. | 2012
- 1963
-
Risk of serious toxicity in 1181 patients treated in phase I clinical trials of predominantly targeted anticancer drugs: the M. D. Anderson Cancer Center experienceWheler, J. J. / Tsimberidou, A. M. / Hong, D. S. / Naing, A. / Falchook, G. S. / Fu, S. / Moulder, S. / Stephen, B. / Wen, S. / Kurzrock, R. et al. | 2012
- 1968
-
Defining the risk of toxicity in phase I oncology trials of novel molecularly targeted agents: a single centre experienceMolife, L. R. / Alam, S. / Olmos, D. / Puglisi, M. / Shah, K. / Fehrmann, R. / Trani, L. / Tjokrowidjaja, A. / de Bono, J. S. / Banerji, U. et al. | 2012
- 1973
-
Clinical biopsychosocial risk factors for depression in lung cancer patients: a comprehensive analysis using data from the Lung Cancer Database ProjectShimizu, K. / Nakaya, N. / Saito-Nakaya, K. / Akechi, T. / Yamada, Y. / Fujimori, M. / Ogawa, A. / Fujisawa, D. / Goto, K. / Iwasaki, M. et al. | 2012
- 1979
-
Deterioration in quality of life (QoL) in patients with malignant ascites: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis aloneWimberger, P. / Gilet, H. / Gonschior, A. K. / Heiss, M. M. / Moehler, M. / Oskay-Oezcelik, G. / Al-Batran, S. E. / Schmalfeldt, B. / Schmittel, A. / Schulze, E. et al. | 2012
- 1986
-
The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER)Aapro, M. / Molassiotis, A. / Dicato, M. / Pelaez, I. / Rodriguez-Lescure, A. / Pastorelli, D. / Ma, L. / Burke, T. / Gu, A. / Gascon, P. et al. | 2012
- 1992
-
Daily skin care habits and the risk of skin eruptions and symptoms in cancer patientsByun, H. J. / Lee, H. J. / Yang, J. I. / Kim, K. H. / Park, K. O. / Park, S. M. / Lee, K. E. / Choi, J. / Noh, D. Y. / Cho, K. H. et al. | 2012
- 1998
-
Cancer effect on periprocedural thromboembolism and bleeding in anticoagulated patientsTafur, A. J. / Wysokinski, W. E. / McBane, R. D. / Wolny, E. / Sutkowska, E. / Litin, S. C. / Daniels, P. R. / Slusser, J. P. / Hodge, D. O. / Heit, J. A. et al. | 2012
- 2006
-
Preferences for place of death if faced with advanced cancer: a population survey in England, Flanders, Germany, Italy, the Netherlands, Portugal and SpainGomes, B. / Higginson, I. J. / Calanzani, N. / Cohen, J. / Deliens, L. / Daveson, B. A. / Bechinger-English, D. / Bausewein, C. / Ferreira, P. L. / Toscani, F. et al. | 2012
- 2016
-
Impact of early access to a palliative/supportive care intervention on pain management in patients with cancerBandieri, E. / Sichetti, D. / Romero, M. / Fanizza, C. / Belfiglio, M. / Buonaccorso, L. / Artioli, F. / Campione, F. / Tognoni, G. / Luppi, M. et al. | 2012
- 2020
-
Health-related quality of life in recurrent platinum-sensitive ovarian cancer-results from the CALYPSO trialBrundage, M. / Gropp, M. / Mefti, F. / Mann, K. / Lund, B. / Gebski, V. / Wolfram, G. / Reed, N. / Pignata, S. / Ferrero, A. et al. | 2012
- 2027
-
Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast cancer: the randomized phase 3 HOBOE studyNuzzo, F. / Gallo, C. / Lastoria, S. / Di Maio, M. / Piccirillo, M. C. / Gravina, A. / Landi, G. / Rossi, E. / Pacilio, C. / Labonia, V. et al. | 2012
- 2034
-
PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumabJensen, J. D. / Knoop, A. / Laenkholm, A. V. / Grauslund, M. / Jensen, M. B. / Santoni-Rugiu, E. / Andersson, M. / Ewertz, M. et al. | 2012
- 2042
-
Multicentric/multifocal breast cancer with a single histotype: is the biological characterization of all individual foci justified?Buggi, F. / Folli, S. / Curcio, A. / Casadei-Giunchi, D. / Rocca, A. / Pietri, E. / Medri, L. / Serra, L. et al. | 2012
- 2046
-
Breast Cancer Index predicts pathological complete response and eligibility for breast conserving surgery in breast cancer patients treated with neoadjuvant chemotherapyMathieu, M. C. / Mazouni, C. / Kesty, N. C. / Zhang, Y. / Scott, V. / Passeron, J. / Arnedos, M. / Schnabel, C. A. / Delaloge, S. / Erlander, M. G. et al. | 2012
- 2053
-
Risk factors associated with recurrence after nipple-sparing mastectomy for invasive and intraepithelial neoplasiaPetit, J. Y. / Veronesi, U. / Orecchia, R. / Curigliano, G. / Rey, P. C. / Botteri, E. / Rotmensz, N. / Lohsiriwat, V. / Cassilha Kneubil, M. / Rietjens, M. et al. | 2012
- 2059
-
Association between the nuclear to cytoplasmic ratio of p27 and the efficacy of adjuvant polychemotherapy in early breast cancerAndre, F. / Conforti, R. / Moeder, C. B. / Mauguen, A. / Arnedos, M. / Berrada, N. / Delaloge, S. / Tomasic, G. / Spielmann, M. / Esteva, F. J. et al. | 2012
- 2065
-
Lacrimal drainage obstruction in gastric cancer patients receiving S-1 chemotherapyKim, N. / Park, C. / Park, D. J. / Kim, H. H. / Kim, S. / Kim, Y. J. / Kim, J. H. / Lee, J. S. / Bang, Y. J. / Khwarg, S. I. et al. | 2012
- 2072
-
Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases studySantini, D. / Tampellini, M. / Vincenzi, B. / Ibrahim, T. / Ortega, C. / Virzi, V. / Silvestris, N. / Berardi, R. / Masini, C. / Calipari, N. et al. | 2012
- 2078
-
To PET or not to PET? That is the question. Staging in anal cancerBhuva, N. J. / Glynne-Jones, R. / Sonoda, L. / Wong, W. L. / Harrison, M. K. et al. | 2012
- 2082
-
Zoledronic acid in patients with stage IIIA/B NSCLC: results of a randomized, phase III studyScagliotti, G. V. / Kosmidis, P. / de Marinis, F. / Schreurs, A. J. / Albert, I. / Engel-Riedel, W. / Schallier, D. / Barbera, S. / Kuo, H. P. / Sallo, V. et al. | 2012
- 2088
-
Proteins involved in DNA damage response pathways and survival of stage I non-small-cell lung cancer patientsChoi, C. M. / Yang, S. C. / Jo, H. J. / Song, S. Y. / Jeon, Y. J. / Jang, T. W. / Kim, D. J. / Jang, S. H. / Yang, S. H. / Kim, Y. D. et al. | 2012
- 2094
-
A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancerDoebele, R. C. / Conkling, P. / Traynor, A. M. / Otterson, G. A. / Zhao, Y. / Wind, S. / Stopfer, P. / Kaiser, R. / Camidge, D. R. et al. | 2012
- 2103
-
Development and validation of a prediction index for hand-foot skin reaction in cancer patients receiving sorafenibDranitsaris, G. / Vincent, M. D. / Yu, J. / Huang, L. / Fang, F. / Lacouture, M. E. et al. | 2012
- 2108
-
Multicenter phase II study of sunitinib in patients with non-clear cell renal cell carcinomaLee, J. L. / Ahn, J. H. / Lim, H. Y. / Park, S. H. / Lee, S. H. / Kim, T. M. / Lee, D. H. / Cho, Y. M. / Song, C. / Hong, J. H. et al. | 2012
- 2114
-
Polymorphisms in the IL-13 and IL-4R genes are associated with the development of renal cell carcinomaChu, H. / Wang, M. / Yan, F. / Zhong, D. / Shi, D. / Ma, L. / Pan, X. / Qin, C. / Yin, C. / Zhang, Z. et al. | 2012
- 2122
-
Early ultrasonographic finding of septic thrombophlebitis is the main indicator of central venous catheter removal to reduce infection-related mortality in neutropenic patients with bloodstream infectionPicardi, M. / Pagliuca, S. / Chiurazzi, F. / Iula, D. / Catania, M. / Rossano, F. / Pane, F. et al. | 2012
- 2128
-
Racial disparities in Hodgkins lymphoma: a comprehensive population-based analysisEvens, A. M. / Antillon, M. / Aschebrook-Kilfoy, B. / Chiu, B. C. et al. | 2012
- 2138
-
Identification of a novel recurrent gain on 20q13 in chronic lymphocytic leukemia by array CGH and gene expression profilingRodriguez, A. E. / Robledo, C. / Garcia, J. L. / Gonzalez, M. / Gutierrez, N. C. / Hernandez, J. A. / Sandoval, V. / Garcia de Coca, A. / Recio, I. / Risueno, A. et al. | 2012
- 2146
-
Identification and validation of gene expression models that predict clinical outcome in patients with early-stage laryngeal cancerFountzilas, E. / Markou, K. / Vlachtsis, K. / Nikolaou, A. / Arapantoni-Dadioti, P. / Ntoula, E. / Tassopoulos, G. / Bobos, M. / Konstantinopoulos, P. / Fountzilas, G. et al. | 2012
- 2153
-
Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02)Schmitz, S. / Kaminsky-Forrett, M. C. / Henry, S. / Zanetta, S. / Geoffrois, L. / Bompas, E. / Moxhon, A. / Mignion, L. / Guigay, J. / Knoops, L. et al. | 2012
- 2161
-
How valid are claims for synergy in published clinical studies?Ocana, A. / Amir, E. / Yeung, C. / Seruga, B. / Tannock, I. F. et al. | 2012
- 2166
-
Screening older cancer patients: first evaluation of the G-8 geriatric screening toolBellera, C. A. / Rainfray, M. / Mathoulin-Pelissier, S. / Mertens, C. / Delva, F. / Fonck, M. / Soubeyran, P. L. et al. | 2012
- 2173
-
History of cholelithiasis and cancer risk in a network of case-control studiesTavani, A. / Rosato, V. / Di Palma, F. / Bosetti, C. / Talamini, R. / Dal Maso, L. / Zucchetto, A. / Levi, F. / Montella, M. / Negri, E. et al. | 2012
- 2179
-
Effect of autoimmune diseases on mortality and survival in subsequent digestive tract cancersHemminki, K. / Liu, X. / Ji, J. / Sundquist, J. / Sundquist, K. et al. | 2012
- 2185
-
High STEAP1 expression is associated with improved outcome of Ewings sarcoma patientsGrunewald, T. G. / Ranft, A. / Esposito, I. / da Silva-Buttkus, P. / Aichler, M. / Baumhoer, D. / Schaefer, K. L. / Ottaviano, L. / Poremba, C. / Jundt, G. et al. | 2012
- 2191
-
The Dutch Childhood Oncology Group guideline for follow-up of asymptomatic cardiac dysfunction in childhood cancer survivorsSieswerda, E. / Postma, A. / van Dalen, E. C. / van der Pal, H. J. / Tissing, W. J. / Rammeloo, L. A. / Kok, W. E. / van Leeuwen, F. E. / Caron, H. N. / Kremer, L. C. et al. | 2012
- 2198
-
Cruciferous vegetables and cancer risk in a network of case-control studiesBosetti, C. / Filomeno, M. / Riso, P. / Polesel, J. / Levi, F. / Talamini, R. / Montella, M. / Negri, E. / Franceschi, S. / La Vecchia, C. et al. | 2012
- 2204
-
Durable complete response following chemotherapy and trastuzumab for metastatic HER2-positive breast cancerGullo, G. / Zuradelli, M. / Sclafani, F. / Santoro, A. / Crown, J. et al. | 2012
- 2205
-
Advanced pleomorphic liposarcomas: clinical outcome and impact of chemotherapyItaliano, A. / Garbay, D. / Cioffi, A. / Maki, R. G. / Bui, B. et al. | 2012
- 2206
-
Pregnancy unbosoms the heart of breast cancer survivorsAltena, R. / Gietema, J. A. / van Veldhuisen, D. J. / Reyners, A. K. et al. | 2012
- 2209
-
Small cell lung cancer and Chemotherapy advances in small cell lung cancer| 2012
- 2211
-
DNA repair protein expression in resected NSCLC: a different predictive value for platinum benefit in adenocarcinoma versus squamous-cell carcinoma?Felip, E. / Martinez-Marti, A. et al. | 2012
- 2215
-
Bone matters in lung cancerBrodowicz, T. / OByrne, K. / Manegold, C. et al. | 2012
- 2223
-
Targeting triple-negative breast cancer: optimising therapeutic outcomesGelmon, K. / Dent, R. / Mackey, J. R. / Laing, K. / McLeod, D. / Verma, S. et al. | 2012
- 2235
-
Alcohol drinking and risk of renal cell carcinoma: results of a meta-analysisBellocco, R. / Pasquali, E. / Rota, M. / Bagnardi, V. / Tramacere, I. / Scotti, L. / Pelucchi, C. / Boffetta, P. / Corrao, G. / La Vecchia, C. et al. | 2012
- 2245
-
Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC constituent histological subclassesPierceall, W. E. / Olaussen, K. A. / Rousseau, V. / Brambilla, E. / Sprott, K. M. / Andre, F. / Pignon, J. P. / Le Chevalier, T. / Pirker, R. / Jiang, C. et al. | 2012
- 2253
-
Induction chemotherapy followed by gefitinib and concurrent thoracic radiotherapy for unresectable locally advanced adenocarcinoma of the lung: a multicenter feasibility study (JCOG 0402)Niho, S. / Ohe, Y. / Ishikura, S. / Atagi, S. / Yokoyama, A. / Ichinose, Y. / Okamoto, H. / Takeda, K. / Shibata, T. / Tamura, T. et al. | 2012
- 2259
-
A randomized phase III adjuvant study in high-risk cervical cancer: simultaneous radiochemotherapy with cisplatin (S-RC) versus systemic paclitaxel and carboplatin followed by percutaneous radiation (PC-R): a NOGGO-AGO Intergroup StudySehouli, J. / Runnebaum, I. B. / Fotopoulou, C. / Blohmer, U. / Belau, A. / Leber, H. / Hanker, L. C. / Hartmann, W. / Richter, R. / Keyver-Paik, M. D. et al. | 2012
- 2265
-
A phase II trial (AGO 2.11) in platinum-resistant ovarian cancer: a randomized multicenter trial with sunitinib (SU11248) to evaluate dosage, schedule, tolerability, toxicity and effectiveness of a multitargeted receptor tyrosine kinase inhibitor monotherapyBaumann, K. H. / du Bois, A. / Meier, W. / Rau, J. / Wimberger, P. / Sehouli, J. / Kurzeder, C. / Hilpert, F. / Hasenburg, A. / Canzler, U. et al. | 2012
- 2271
-
Influence of zoledronic acid on disseminated tumor cells in primary breast cancer patientsSolomayer, E. F. / Gebauer, G. / Hirnle, P. / Janni, W. / Luck, H. J. / Becker, S. / Huober, J. / Kramer, B. / Wackwitz, B. / Wallwiener, D. et al. | 2012
- 2277
-
Preoperative PET/CT in early-stage breast cancerBernsdorf, M. / Berthelsen, A. K. / Wielenga, V. T. / Kroman, N. / Teilum, D. / Binderup, T. / Tange, U. B. / Andersson, M. / Kjaer, A. / Loft, A. et al. | 2012
- 2283
-
Resumption or persistence of menstruation after cytotoxic chemotherapy is a prognostic factor for poor disease-free survival in premenopausal patients with early breast cancerPark, I. H. / Han, H. S. / Lee, H. / Lee, K. S. / Kang, H. S. / Lee, S. / Kim, S. W. / Jung, S. / Ro, J. et al. | 2012
- 2289
-
Calpain system protein expression in basal-like and triple-negative invasive breast cancerStorr, S. J. / Lee, K. W. / Woolston, C. M. / Safuan, S. / Green, A. R. / Macmillan, R. D. / Benhasouna, A. / Parr, T. / Ellis, I. O. / Martin, S. G. et al. | 2012
- 2296
-
A randomised trial of primary tamoxifen versus mastectomy plus adjuvant tamoxifen in fit elderly women with invasive breast carcinoma of high oestrogen receptor content: long-term results at 20 years of follow-upJohnston, S. J. / Kenny, F. S. / Syed, B. M. / Robertson, J. F. / Pinder, S. E. / Winterbottom, L. / Ellis, I. O. / Blamey, R. W. / Cheung, K. L. et al. | 2012
- 2301
-
Clinical correlates of `BRCAness' in triple-negative breast cancer of patients receiving adjuvant chemotherapyOonk, A. M. / van Rijn, C. / Smits, M. M. / Mulder, L. / Laddach, N. / Savola, S. P. / Wesseling, J. / Rodenhuis, S. / Imholz, A. L. / Lips, E. H. et al. | 2012
- 2306
-
Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with EpCAM-positive relapsed or refractory advanced-stage breast cancerSchmidt, M. / Ruttinger, D. / Sebastian, M. / Hanusch, C. A. / Marschner, N. / Baeuerle, P. A. / Wolf, A. / Goppel, G. / Oruzio, D. / Schlimok, G. et al. | 2012
- 2313
-
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?Santini, D. / Vincenzi, B. / Addeo, R. / Garufi, C. / Masi, G. / Scartozzi, M. / Mancuso, A. / Frezza, A. M. / Venditti, O. / Imperatori, M. et al. | 2012
- 2319
-
Red and processed meat consumption and the risk of esophageal and gastric cancer subtypes in The Netherlands Cohort StudyKeszei, A. P. / Schouten, L. J. / Goldbohm, R. A. / van den Brandt, P. A. et al. | 2012
- 2327
-
Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinomaBachet, J. B. / Marechal, R. / Demetter, P. / Bonnetain, F. / Couvelard, A. / Svrcek, M. / Bardier-Dupas, A. / Hammel, P. / Sauvanet, A. / Louvet, C. et al. | 2012
- 2335
-
A phase II clinical trial of sunitinib following hepatic transarterial embolization for metastatic neuroendocrine tumorsStrosberg, J. R. / Weber, J. M. / Choi, J. / Campos, T. L. / Valone, T. L. / Han, G. / Schell, M. J. / Kvols, L. K. et al. | 2012
- 2341
-
Phase II marker-driven trial of panitumumab and chemotherapy in KRAS wild-type biliary tract cancerJensen, L. H. / Lindebjerg, J. / Ploen, J. / Hansen, T. F. / Jakobsen, A. et al. | 2012
- 2346
-
Addition of short-term androgen deprivation therapy to dose-escalated radiation therapy improves failure-free survival for select men with intermediate-risk prostate cancerBian, S. X. / Kuban, D. A. / Levy, L. B. / Oh, J. / Castle, K. O. / Pugh, T. J. / Choi, S. / McGuire, S. E. / Nguyen, Q. N. / Frank, S. J. et al. | 2012
- 2352
-
Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: a CellSearch analysisGazzaniga, P. / Gradilone, A. / de Berardinis, E. / Busetto, G. M. / Raimondi, C. / Gandini, O. / Nicolazzo, C. / Petracca, A. / Vincenzi, B. / Farcomeni, A. et al. | 2012
- 2356
-
Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsivenessCzuczman, M. S. / Leonard, J. P. / Jung, S. / Johnson, J. L. / Hsi, E. D. / Byrd, J. C. / Cheson, B. D. et al. | 2012
- 2362
-
Menstrual and reproductive factors, and hormonal contraception use: associations with non-Hodgkin lymphoma in a pooled analysis of InterLymph case-control studiesKane, E. V. / Roman, E. / Becker, N. / Bernstein, L. / Boffetta, P. / Bracci, P. M. / Cerhan, J. R. / Chiu, B. C. / Cocco, P. / Costas, L. et al. | 2012
- 2374
-
Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trialKorfel, A. / Weller, M. / Martus, P. / Roth, P. / Klasen, H. A. / Roeth, A. / Rauch, M. / Hertenstein, B. / Fischer, T. / Hundsberger, T. et al. | 2012
- 2380
-
Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-upColombat, P. / Brousse, N. / Salles, G. / Morschhauser, F. / Brice, P. / Soubeyran, P. / Delwail, V. / Deconinck, E. / Haioun, C. / Foussard, C. et al. | 2012
- 2386
-
Extracorporeal photopheresis as a curative treatment strategy in non epidermotropic T-cell lymphoma and large granular lymphocyte leukemiaGarban, F. / Carras, S. / Drillat, P. / Jacob, M. C. / Fabre, B. / Callanan, M. / Courby, S. / Makowski, C. / Cahn, J. Y. / Gressin, R. et al. | 2012
- 2391
-
Treatment of oropharyngeal squamous cell carcinoma with IMRT: patterns of failure after concurrent chemoradiotherapy and sequential therapySher, D. J. / Thotakura, V. / Balboni, T. A. / Norris, C. M. / Haddad, R. I. / Posner, M. R. / Lorch, J. / Goguen, L. A. / Annino, D. J. / Tishler, R. B. et al. | 2012
- 2399
-
Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumorsMarkman, B. / Tabernero, J. / Krop, I. / Shapiro, G. I. / Siu, L. / Chen, L. C. / Mita, M. / Melendez Cuero, M. / Stutvoet, S. / Birle, D. et al. | 2012
- 2409
-
Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitorsSchirosi, L. / Nannini, N. / Nicoli, D. / Cavazza, A. / Valli, R. / Buti, S. / Garagnani, L. / Sartori, G. / Calabrese, F. / Marchetti, A. et al. | 2012
- 2415
-
Elevated serum antibodies against insulin-like growth factor-binding protein-2 allow detecting early-stage cancers: evidences from glioma and colorectal carcinoma studiesLi, Y. / Jiang, T. / Zhang, J. / Zhang, B. / Yang, W. / You, G. / Xu, K. / Wu, J. / Luo, C. / Song, S. W. et al. | 2012
- 2422
-
The role of comorbidities on the uptake of systemic treatment and 3-year survival in older cancer patientsStavrou, E. P. / Lu, C. Y. / Buckley, N. / Pearson, S. et al. | 2012
- 2428
-
Changes in survival by ethnicity of patients with cancer between 1992-1996 and 2002-2006: is the discrepancy decreasing?Pulte, D. / Redaniel, M. T. / Brenner, H. / Jeffreys, M. et al. | 2012
- 2435
-
Reproductive and hormonal risk factors for luminal, HER2-overexpressing, and triple-negative breast cancer in Japanese womenIslam, T. / Matsuo, K. / Ito, H. / Hosono, S. / Watanabe, M. / Iwata, H. / Tajima, K. / Tanaka, H. et al. | 2012
- 2442
-
Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regionsRay-Coquard, I. / Montesco, M. C. / Coindre, J. M. / Dei Tos, A. P. / Lurkin, A. / Ranchere-Vince, D. / Vecchiato, A. / Decouvelaere, A. V. / Mathoulin-Pelissier, S. / Albert, S. et al. | 2012
- 2449
-
Effect of radiation therapy on survival in surgically resected retroperitoneal sarcoma: a propensity score-adjusted SEER analysisChoi, A. H. / Barnholtz-Sloan, J. S. / Kim, J. A. et al. | 2012
- 2457
-
Treatment and outcome of Wilms tumour patients: an analysis of all cases registered in the UKW3 trialPritchard-Jones, K. / Moroz, V. / Vujanic, G. / Powis, M. / Walker, J. / Messahel, B. / Hobson, R. / Levitt, G. / Kelsey, A. / Mitchell, C. et al. | 2012
- 2464
-
Population survival from childhood cancer in Britain during 1978-2005 by eras of entry to clinical trialsStiller, C. A. / Kroll, M. E. / Pritchard-Jones, K. et al. | 2012
- 2470
-
Concomitant use of pazopanib and simvastatin increases the risk of transaminase elevations in patients with cancerdaggerXu, C. F. / Xue, Z. / Bing, N. / King, K. S. / McCann, L. A. / de Souza, P. L. / Goodman, V. L. / Spraggs, C. F. / Mooser, V. E. / Pandite, L. N. et al. | 2012
- 2473
-
Novel therapies for advanced prostate cancer: have we have widened the goal posts too far?Raghavan, D. et al. | 2012
- 2475
-
Cognitive complaints in women with breast cancer: cross-cultural considerationsRibi, K. et al. | 2012
- 2479
-
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision makingSchmoll, H. J. / Van Cutsem, E. / Stein, A. / Valentini, V. / Glimelius, B. / Haustermans, K. / Nordlinger, B. / van de Velde, C. J. / Balmana, J. / Regula, J. et al. | 2012
- 2517
-
Neoadjuvant chemotherapy in MRI-staged high-risk rectal cancer in addition to or as an alternative to preoperative chemoradiation?Glynne-Jones, R. / Anyamene, N. / Moran, B. / Harrison, M. et al. | 2012
- 2526
-
mTOR inhibitors in the management of hormone receptor-positive breast cancer: the latest evidence and future directionsVillarreal-Garza, C. / Cortes, J. / Andre, F. / Verma, S. et al. | 2012
- 2536
-
Dietary fructose, carbohydrates, glycemic indices and pancreatic cancer risk: a systematic review and meta-analysis of cohort studiesAune, D. / Chan, D. S. / Vieira, A. R. / Navarro Rosenblatt, D. A. / Vieira, R. / Greenwood, D. C. / Cade, J. E. / Burley, V. J. / Norat, T. et al. | 2012
- 2547
-
Cognitive changes in multiethnic Asian breast cancer patients: a focus group studyCheung, Y. T. / Shwe, M. / Tan, Y. P. / Fan, G. / Ng, R. / Chan, A. et al. | 2012
- 2552
-
FOXP3 expression in cancer cells and anthracyclines efficacy in patients with primary breast cancer treated with adjuvant chemotherapy in the phase III UNICANCER-PACS 01 trialLadoire, S. / Mignot, G. / Dalban, C. / Chevriaux, A. / Arnould, L. / Rebe, C. / Apetoh, L. / Boidot, R. / Penault-Llorca, F. / Fumoleau, P. et al. | 2012
- 2561
-
Relevant impact of central pathology review on nodal classification in individual breast cancer patientsVestjens, J. H. / Pepels, M. J. / de Boer, M. / Borm, G. F. / van Deurzen, C. H. / van Diest, P. J. / van Dijck, J. A. / Adang, E. M. / Nortier, J. W. / Rutgers, E. J. et al. | 2012
- 2566
-
Correlation of treatment-emergent adverse events and clinical response to endocrine therapy in early breast cancer: a retrospective analysis of the German cohort of TEAMHadji, P. / Kieback, D. G. / Tams, J. / Hasenburg, A. / Ziller, M. et al. | 2012
- 2572
-
Changes in 18F-FDG tumor metabolism after a first course of neoadjuvant chemotherapy in breast cancer: influence of tumor subtypesHumbert, O. / Berriolo-Riedinger, A. / Riedinger, J. M. / Coudert, B. / Arnould, L. / Cochet, A. / Loustalot, C. / Fumoleau, P. / Brunotte, F. et al. | 2012
- 2578
-
Applying the 2011 St Gallen panel of prognostic markers on a large single hospital cohort of consecutively treated primary operable breast cancersBrouckaert, O. / Laenen, A. / Vanderhaegen, J. / Wildiers, H. / Leunen, K. / Amant, F. / Berteloot, P. / Smeets, A. / Paridaens, R. / Christiaens, M. R. et al. | 2012
- 2585
-
Cost-effectiveness of adjuvant systemic therapy in low-risk breast cancer patients with nodal isolated tumor cells or micrometastasesde Boer, M. / Adang, E. M. / Van Dycke, K. C. / van Dijck, J. A. / Borm, G. F. / Seferina, S. C. / van Deurzen, C. H. / van Diest, P. J. / Bult, P. / Donders, A. R. et al. | 2012
- 2591
-
Long-term cosmetic changes after breast-conserving treatment of patients with stage I-II breast cancer and included in the EORTC `boost versus no boost' trialImmink, J. M. / Putter, H. / Bartelink, H. / Cardoso, J. S. / Cardoso, M. J. / van der Hulst-Vijgen, M. H. / Noordijk, E. M. / Poortmans, P. M. / Rodenhuis, C. C. / Struikmans, H. et al. | 2012
- 2599
-
Pegylated liposomal doxorubicin plus carboplatin in patients with metastatic breast cancer: a phase II studyCollea, R. P. / Kruter, F. W. / Cantrell, J. E. / George, T. K. / Kruger, S. / Favret, A. M. / Lindquist, D. L. / Melnyk, A. M. / Pluenneke, R. E. / Shao, S. H. et al. | 2012
- 2605
-
The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane/platinum-based therapyHanker, L. C. / Loibl, S. / Burchardi, N. / Pfisterer, J. / Meier, W. / Pujade-Lauraine, E. / Ray-Coquard, I. / Sehouli, J. / Harter, P. / du Bois, A. et al. | 2012
- 2613
-
First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)-a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTGLindemann, K. / Christensen, R. D. / Vergote, I. / Stuart, G. / Izquierdo, M. A. / Kaern, J. / Havsteen, H. / Eisenhauer, E. / Ridderheim, M. / Lopez, A. B. et al. | 2012
- 2619
-
Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004)Ruers, T. / Punt, C. / Van Coevorden, F. / Pierie, J. P. / Borel-Rinkes, I. / Ledermann, J. A. / Poston, G. / Bechstein, W. / Lentz, M. A. / Mauer, M. et al. | 2012
- 2627
-
Induction chemotherapy with capecitabine and oxaliplatin followed by chemoradiotherapy before total mesorectal excision in patients with locally advanced rectal cancerSchou, J. V. / Larsen, F. O. / Rasch, L. / Linnemann, D. / Langhoff, J. / Hogdall, E. / Nielsen, D. L. / Vistisen, K. / Fromm, A. / Jensen, B. V. et al. | 2012
- 2633
-
An initial watch and wait approach is a valid strategy for selected patients with newly diagnosed metastatic colorectal cancerVoskoboynik, M. / Bae, S. / Ananda, S. / Desai, J. / Kosmider, S. / Gibbs, P. et al. | 2012
- 2638
-
Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancerAjani, J. A. / Correa, A. M. / Hofstetter, W. L. / Rice, D. C. / Blum, M. A. / Suzuki, A. / Taketa, T. / Welsh, J. / Lin, S. H. / Lee, J. H. et al. | 2012
- 2642
-
Survival analysis and prognostic nomogram for patients undergoing resection of extrahepatic cholangiocarcinomavan der Gaag, N. A. / Kloek, J. J. / de Bakker, J. K. / Musters, B. / Geskus, R. B. / Busch, O. R. / Bosma, A. / Gouma, D. J. / van Gulik, T. M. et al. | 2012
- 2649
-
Colorectal cancer pulmonary oligometastases: pooled analysis and construction of a clinical lung metastasectomy prognostic modelSalah, S. / Watanabe, K. / Welter, S. / Park, J. S. / Park, J. W. / Zabaleta, J. / Ardissone, F. / Kim, J. / Riquet, M. / Nojiri, K. et al. | 2012
- 2656
-
Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysisJanjigian, Y. Y. / Werner, D. / Pauligk, C. / Steinmetz, K. / Kelsen, D. P. / Jager, E. / Altmannsberger, H. M. / Robinson, E. / Tafe, L. J. / Tang, L. H. et al. | 2012
- 2663
-
Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkersSeront, E. / Rottey, S. / Sautois, B. / Kerger, J. / DHondt, L. A. / Verschaeve, V. / Canon, J. L. / Dopchie, C. / Vandenbulcke, J. M. / Whenham, N. et al. | 2012
- 2670
-
Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma-a long-term follow-up studyKasenda, B. / Schorb, E. / Fritsch, K. / Finke, J. / Illerhaus, G. et al. | 2012
- 2676
-
Centralised multidisciplinary re-evaluation of diagnostic procedures in patients with newly diagnosed Hodgkin lymphomaStevens, W. B. / van Krieken, J. H. / Mus, R. D. / Arens, A. I. / Mattijssen, V. / Oosterveld, M. / de Kruijf, E. J. / de Vries, F. / Koster, A. / van der Maazen, R. et al. | 2012
- 2681
-
Circulating activin-A is elevated in patients with advanced multiple myeloma and correlates with extensive bone involvement and inferior survival; no alterations post-lenalidomide and dexamethasone therapyTerpos, E. / Kastritis, E. / Christoulas, D. / Gkotzamanidou, M. / Eleutherakis-Papaiakovou, E. / Kanellias, N. / Papatheodorou, A. / Dimopoulos, M. A. et al. | 2012
- 2687
-
A 4-weekly course of rituximab is safe and improves tumor control for patients with minimal residual disease persisting 3 months after autologous hematopoietic stem-cell transplantation: results of a prospective multicenter phase II study in patients with follicular lymphomaMorschhauser, F. / Recher, C. / Milpied, N. / Gressin, R. / Salles, G. / Brice, P. / Vey, N. / Haioun, C. / Colombat, P. / Rossi, J. F. et al. | 2012
- 2695
-
Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experienceLe Gouill, S. / Kroger, N. / Dhedin, N. / Nagler, A. / Bouabdallah, K. / Yakoub-Agha, I. / Kanouni, T. / Bulabois, C. E. / Tournilhac, O. / Buzyn, A. et al. | 2012
- 2703
-
Extranodal natural killer/T-cell lymphoma from skin or soft tissue: suggestion of treatment from multinational retrospective analysisAhn, H. K. / Suh, C. / Chuang, S. S. / Suzumiya, J. / Ko, Y. H. / Kim, S. J. / Huh, J. R. / Yoon, D. H. / Oh, S. Y. / Kim, J. S. et al. | 2012
- 2708
-
Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891Lefebvre, J. L. / Andry, G. / Chevalier, D. / Luboinski, B. / Collette, L. / Traissac, L. / de Raucourt, D. / Langendijk, J. A. et al. | 2012
- 2714
-
A phase I/IIA study of AGS-PSCA for castration-resistant prostate cancerMorris, M. J. / Eisenberger, M. A. / Pili, R. / Denmeade, S. R. / Rathkopf, D. / Slovin, S. F. / Farrelly, J. / Chudow, J. J. / Vincent, M. / Scher, H. I. et al. | 2012
- 2720
-
Cancer of unknown primary (CUP): does cause of death and family history implicate hidden phenotypically changed primaries?Hemminki, K. / Bevier, M. / Sundquist, J. / Hemminki, A. et al. | 2012
- 2725
-
Intracellular signalling via the AKT axis and downstream effectors is active and prognostically significant in cancer of unknown primary (CUP): a study of 100 CUP casesGolfinopoulos, V. / Pentheroudakis, G. / Goussia, A. / Siozopoulou, V. / Bobos, M. / Krikelis, D. / Cervantes, A. / Ciuleanu, T. / Marselos, M. / Fountzilas, G. et al. | 2012
- 2731
-
The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgeryYun, Y. H. / Kim, Y. A. / Min, Y. H. / Park, S. / Won, Y. J. / Kim, D. Y. / Choi, I. J. / Kim, Y. W. / Park, S. J. / Kim, J. H. et al. | 2012
- 2737
-
Dietary folates and cancer risk in a network of case-control studiesTavani, A. / Malerba, S. / Pelucchi, C. / Dal Maso, L. / Zucchetto, A. / Serraino, D. / Levi, F. / Montella, M. / Franceschi, S. / Zambon, A. et al. | 2012
- 2743
-
Early-stage lung cancer in elderly patients: A population-based study of changes in treatment patterns and survival in the NetherlandsHaasbeek, C. J. / Palma, D. / Visser, O. / Lagerwaard, F. J. / Slotman, B. / Senan, S. et al. | 2012
- 2748
-
Geographic distribution of hematopoietic cancers in the Nile delta of EgyptHerzog, C. M. / Dey, S. / Hablas, A. / Khaled, H. M. / Seifeldin, I. A. / Ramadan, M. / El-Hamzawy, H. / Wilson, M. L. / Soliman, A. S. et al. | 2012
- 2755
-
Trends in cancer mortality in China: an updateGuo, P. / Huang, Z. L. / Yu, P. / Li, K. et al. | 2012
- 2763
-
Chemotherapy treatment patterns and clinical outcomes in patients with metastatic soft tissue sarcoma. The SArcoma treatment and Burden of Illness in North America and Europe (SABINE) studyLeahy, M. / Garcia del Muro, X. / Reichardt, P. / Judson, I. / Staddon, A. / Verweij, J. / Baffoe-Bonnie, A. / Jonsson, L. / Musayev, A. / Justo, N. et al. | 2012
- 2771
-
Reply to FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer-subgroup analysis of patients with KRAS-mutated tumours in the randomised German AIO study KRK-0306Pietrantonio, F. / Garassino, M. C. / Torri, V. / de Braud, F. et al. | 2012
- 2772
-
Association of telomerase expression with recurrence of sacral chordomaHu, H. / Yang, H. L. / Lu, J. / Chen, K. W. / Qiu, Y. H. / Liu, W. / Luo, Z. P. et al. | 2012
- 2775
-
Hope: oncologys missing breakthroughCorn, B. W. et al. | 2012
- 2776
-
Adjuvant therapy in primary GIST: state-of-the-artReichardt, P. / Blay, J. Y. / Boukovinas, I. / Brodowicz, T. / Broto, J. M. / Casali, P. G. / Decatris, M. / Eriksson, M. / Gelderblom, H. / Kosmidis, P. et al. | 2012
- 2782
-
The impact of menopause on bone, zoledronic acid, and implications for breast cancer growth and metastasisHadji, P. / Coleman, R. / Gnant, M. / Green, J. et al. | 2012
- 2791
-
Alcohol drinking and non-Hodgkin lymphoma risk: a systematic review and a meta-analysisTramacere, I. / Pelucchi, C. / Bonifazi, M. / Bagnardi, V. / Rota, M. / Bellocco, R. / Scotti, L. / Islami, F. / Corrao, G. / Boffetta, P. et al. | 2012
- 2799
-
BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancerGoncalves, A. / Gilabert, M. / Francois, E. / Dahan, L. / Perrier, H. / Lamy, R. / Re, D. / Largillier, R. / Gasmi, M. / Tchiknavorian, X. et al. | 2012
- 2805
-
Increased adjuvant treatment and improved survival in elderly stage III colon cancer patients in The Netherlandsvan Steenbergen, L. N. / Lemmens, V. E. / Rutten, H. J. / Wymenga, A. N. / Nortier, J. W. / Janssen-Heijnen, M. L. et al. | 2012
- 2812
-
VEGF remains an interesting target in advanced pancreas cancer (APCA): results of a multi-institutional phase II study of bevacizumab, gemcitabine, and infusional 5-fluorouracil in patients with APCAMartin, L. K. / Li, X. / Kleiber, B. / Ellison, E. C. / Bloomston, M. / Zalupski, M. / Bekaii-Saab, T. S. et al. | 2012
- 2820
-
Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinomaPipas, J. M. / Zaki, B. I. / McGowan, M. M. / Tsapakos, M. J. / Ripple, G. H. / Suriawinata, A. A. / Tsongalis, G. J. / Colacchio, T. A. / Gordon, S. R. / Sutton, J. E. et al. | 2012
- 2827
-
Perioperative chemotherapy with docetaxel, cisplatin and capecitabine (DCX) in gastro-oesophageal adenocarcinoma: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)daggerThuss-Patience, P. C. / Hofheinz, R. D. / Arnold, D. / Florschutz, A. / Daum, S. / Kretzschmar, A. / Mantovani-Loffler, L. / Bichev, D. / Breithaupt, K. / Kneba, M. et al. | 2012
- 2834
-
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancerKindler, H. L. / Richards, D. A. / Garbo, L. E. / Garon, E. B. / Stephenson, J. J. / Rocha-Lima, C. M. / Safran, H. / Chan, D. / Kocs, D. M. / Galimi, F. et al. | 2012
- 2843
-
Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trialsHuober, J. / Gelber, S. / Goldhirsch, A. / Coates, A. S. / Viale, G. / Ohlschlegel, C. / Price, K. N. / Gelber, R. D. / Regan, M. M. / Thurlimann, B. et al. | 2012
- 2852
-
Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group reportKarlsson, P. / Cole, B. F. / Chua, B. H. / Price, K. N. / Lindtner, J. / Collins, J. P. / Kovacs, A. / Thurlimann, B. / Crivellari, D. / Castiglione-Gertsch, M. et al. | 2012
- 2859
-
Effect of adjuvant chemotherapy in postmenopausal patients with invasive ductal versus lobular breast cancerTruin, W. / Voogd, A. C. / Vreugdenhil, G. / van der Heiden-van der Loo, M. / Siesling, S. / Roumen, R. M. et al. | 2012
- 2866
-
Concordance among gene expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifenPrat, A. / Parker, J. S. / Fan, C. / Cheang, M. C. / Miller, L. D. / Bergh, J. / Chia, S. K. / Bernard, P. S. / Nielsen, T. O. / Ellis, M. J. et al. | 2012
- 2873
-
Explanatory factors of sexual function in sexual minority women breast cancer survivorsBoehmer, U. / Timm, A. / Ozonoff, A. / Potter, J. et al. | 2012
- 2879
-
Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patientsKluger, N. / Jacot, W. / Frouin, E. / Rigau, V. / Poujol, S. / Dereure, O. / Guillot, B. / Romieu, G. / Bessis, D. et al. | 2012
- 2884
-
Outcome and clinical-biological characteristics of patients with advanced breast cancer undergoing removal of ovarian/pelvic metastasesMunzone, E. / Botteri, E. / Esposito, A. / Sciandivasci, A. / Franchi, D. / Pruneri, G. / Rotmensz, N. / Curigliano, G. / Adamoli, L. / Bocciolone, L. et al. | 2012
- 2890
-
Post-cancer fatigue is not associated with immune activation or altered cytokine productionCameron, B. A. / Bennett, B. / Li, H. / Boyle, F. / deSouza, P. / Wilcken, N. / Friedlander, M. / Goldstein, D. / Lloyd, A. R. et al. | 2012
- 2896
-
A randomized phase II study investigating the addition of the specific COX-2 inhibitor celecoxib to docetaxel plus carboplatin as first-line chemotherapy for stage IC to IV epithelial ovarian cancer, Fallopian tube or primary peritoneal carcinomas: the DoCaCel studyReyners, A. K. / de Munck, L. / Erdkamp, F. L. / Smit, W. M. / Hoekman, K. / Lalisang, R. I. / de Graaf, H. / Wymenga, A. N. / Polee, M. / Hollema, H. et al. | 2012
- 2903
-
Human chorionic gonadotropin (hCG) regression normograms for patients with high-risk gestational trophoblastic neoplasia treated with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapyLybol, C. / Westerdijk, K. / Sweep, F. C. / Ottevanger, P. B. / Massuger, L. F. / Thomas, C. M. et al. | 2012
- 2907
-
ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinomaIlie, M. / Long, E. / Butori, C. / Hofman, V. / Coelle, C. / Mauro, V. / Zahaf, K. / Marquette, C. H. / Mouroux, J. / Paterlini-Brechot, P. et al. | 2012
- 2914
-
An evaluation study of EGFR mutation tests utilized for non-small-cell lung cancer in the diagnostic settingGoto, K. / Satouchi, M. / Ishii, G. / Nishio, K. / Hagiwara, K. / Mitsudomi, T. / Whiteley, J. / Donald, E. / McCormack, R. / Todo, T. et al. | 2012
- 2919
-
Prophylactic cranial irradiation in small-cell lung cancer: Findings from a North Central Cancer Treatment Group Pooled AnalysisSchild, S. E. / Foster, N. R. / Meyers, J. P. / Ross, H. J. / Stella, P. J. / Garces, Y. I. / Olivier, K. R. / Molina, J. R. / Past, L. R. / Adjei, A. A. et al. | 2012
- 2925
-
A randomized phase II study of irinotecan plus cisplatin versus irinotecan plus capecitabine with or without isosorbide-5-mononitrate in advanced non-small-cell lung cancerHan, J. Y. / Nam, B. H. / Kim, H. Y. / Yoon, S. J. / Kim, H. T. / Lee, J. S. et al. | 2012
- 2931
-
Clinical outcome for EML4-ALK-positive patients with advanced non-small-cell lung cancer treated with first-line platinum-based chemotherapyTakeda, M. / Okamoto, I. / Sakai, K. / Kawakami, H. / Nishio, K. / Nakagawa, K. et al. | 2012
- 2937
-
Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factorHiltermann, T. J. / Pore, M. M. / van den Berg, A. / Timens, W. / Boezen, H. M. / Liesker, J. J. / Schouwink, J. H. / Wijnands, W. J. / Kerner, G. S. / Kruyt, F. A. et al. | 2012
- 2943
-
Antitumour activity of docetaxel following treatment with the CYP17A1 inhibitor abiraterone: clinical evidence for cross-resistance?Mezynski, J. / Pezaro, C. / Bianchini, D. / Zivi, A. / Sandhu, S. / Thompson, E. / Hunt, J. / Sheridan, E. / Baikady, B. / Sarvadikar, A. et al. | 2012
- 2948
-
Brachytherapy after external beam radiotherapy and limited surgery preserves bladders for patients with solitary pT1-pT3 bladder tumorsKoning,, C. C. / Blank, L. E. / Koedooder, C. / van Os, R. M. / van de Kar, M. / Jansen, E. / Battermann, J. J. / Beijert, M. / Gernaat, C. / van Herpen, K. A. et al. | 2012
- 2953
-
Comparing long-term toxicity and efficacy of combined modality treatment including extended- or involved-field radiotherapy in early-stage Hodgkins lymphomaSasse, S. / Klimm, B. / Gorgen, H. / Fuchs, M. / Heyden-Honerkamp, A. / Lohri, A. / Koch, O. / Wilhelm, M. / Trenn, G. / Finke, J. et al. | 2012
- 2960
-
Electrocardiograms (ECGs) in phase I anticancer drug development: the MD Anderson Cancer Center experience with 8518 ECGsNaing, A. / Veasey-Rodrigues, H. / Hong, D. S. / Fu, S. / Falchook, G. S. / Wheler, J. J. / Tsimberidou, A. M. / Wen, S. / Fessahaye, S. N. / Golden, E. C. et al. | 2012
- 2964
-
Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4)Duell, E. J. / Lucenteforte, E. / Olson, S. H. / Bracci, P. M. / Li, D. / Risch, H. A. / Silverman, D. T. / Ji, B. T. / Gallinger, S. / Holly, E. A. et al. | 2012
- 2970
-
Primary metastatic Ewings family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiationLuksch, R. / Tienghi, A. / Hall, K. S. / Fagioli, F. / Picci, P. / Barbieri, E. / Gandola, L. / Eriksson, M. / Ruggieri, P. / Daolio, P. et al. | 2012
- 2977
-
Comparison of absolute benefits of anticancer therapies determined by snapshot and area methodsSeruga, B. / Pond, G. R. / Hertz, P. C. / Amir, E. / Ocana, A. / Tannock, I. F. et al. | 2012
- 2983
-
Attributable causes of cancer in ChinaWang, J. B. / Jiang, Y. / Liang, H. / Li, P. / Xiao, H. J. / Ji, J. / Xiang, W. / Shi, J. F. / Fan, Y. G. / Li, L. et al. | 2012
- 2990
-
Adjuvant endocrine therapy with tamoxifen: side-effects on the female genital tract are not always what they seemMourits, M. J. / Buijs, C. et al. | 2012
- 2990
-
Lobular endocervical glandular hyperplasia and peritoneal pigmentation associated with Peutz-Jeghers syndrome due to a germline mutation of STK11Hirasawa, A. / Akahane, T. / Tsuruta, T. / Kobayashi, Y. / Masuda, K. / Banno, K. / Fujii, T. / Susumu, N. / Itsubo, T. / Kameyama, K. et al. | 2012
- 2992
-
Hemodialysis does not affect everolimus pharmacokinetics: two cases of patients with metastatic renal cell cancerThiery-Vuillemin, A. / Curtit, E. / Maurina, T. / Montange, D. / Succi, C. / NGuyen, T. / Kim, S. / Montcuquet, P. / Pivot, X. / Royer, B. et al. | 2012
- 2993
-
Meat consumption and cancer risk: is the definition of red meat always suitable?Lippi, G. / Mattiuzzi, C. et al. | 2012
- 2995
-
Putting public health back into the global cancer agendaSullivan, R. et al. | 2012
- 2997
-
Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group StatementdaggerGuiu, S. / Michiels, S. / Andre, F. / Cortes, J. / Denkert, C. / Di Leo, A. / Hennessy, B. T. / Sorlie, T. / Sotiriou, C. / Turner, N. et al. | 2012
- 3007
-
Overcoming resistance and restoring sensitivity to HER2-targeted therapies in breast cancerMohd Sharial, M. S. / Crown, J. / Hennessy, B. T. et al. | 2012
- 3016
-
Maternal and fetal outcomes of taxane chemotherapy in breast and ovarian cancer during pregnancy: case series and review of the literatureCardonick, E. / Bhat, A. / Gilmandyar, D. / Somer, R. et al. | 2012
- 3024
-
Dietary patterns and upper aerodigestive tract cancers: an overview and reviewBravi, F. / Edefonti, V. / Randi, G. / Ferraroni, M. / La Vecchia, C. / Decarli, A. et al. | 2012
- 3040
-
Public health oncology: a framework for progress in low- and middle-income countriesdaggerLove, R. R. / Ginsburg, O. M. / Coleman, C. N. et al. | 2012
- 3045
-
Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic aciddaggerVadhan-Raj, S. / von Moos, R. / Fallowfield, L. J. / Patrick, D. L. / Goldwasser, F. / Cleeland, C. S. / Henry, D. H. / Novello, S. / Hungria, V. / Qian, Y. et al. | 2012
- 3051
-
Clinicopathological analysis of GATA3-positive breast cancers with special reference to response to neoadjuvant chemotherapyTominaga, N. / Naoi, Y. / Shimazu, K. / Nakayama, T. / Maruyama, N. / Shimomura, A. / Kim, S. J. / Tamaki, Y. / Noguchi, S. et al. | 2012
- 3058
-
Adjuvant trastuzumab cardiotoxicity in patients over 60 years of age with early breast cancer: a multicenter cohort analysisTarantini, L. / Gori, S. / Faggiano, P. / Pulignano, G. / Simoncini, E. / Tuccia, F. / Ceccherini, R. / Bovelli, D. / Lestuzzi, C. / Cioffi, G. et al. | 2012
- 3063
-
Multifocality and multicentricity in breast cancer and survival outcomesLynch, S. P. / Lei, X. / Chavez-MacGregor, M. / Hsu, L. / Meric-Bernstam, F. / Buchholz, T. A. / Zhang, A. / Hortobagyi, G. N. / Valero, V. / Gonzalez-Angulo, A. M. et al. | 2012
- 3069
-
Chemotherapy (CT) and hormonotherapy (HT) as neoadjuvant treatment in luminal breast cancer patients: results from the GEICAM/2006-03, a multicenter, randomized, phase-II studyAlba, E. / Calvo, L. / Albanell, J. / De la Haba, J. R. / Arcusa Lanza, A. / Chacon, J. I. / Sanchez-Rovira, P. / Plazaola, A. / Lopez Garcia-Asenjo, J. A. / Bermejo, B. et al. | 2012
- 3075
-
Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907)Ruddy, K. J. / Pitcher, B. N. / Archer, L. E. / Cohen, H. J. / Winer, E. P. / Hudis, C. A. / Muss, H. B. / Partridge, A. H. et al. | 2012
- 3081
-
Risk of treatment-related esophageal cancer among breast cancer survivorsMorton, L. M. / Gilbert, E. S. / Hall, P. / Andersson, M. / Joensuu, H. / Vaalavirta, L. / Dores, G. M. / Stovall, M. / Holowaty, E. J. / Lynch, C. F. et al. | 2012
- 3091
-
Relationship between specific adverse events and efficacy of exemestane therapy in early postmenopausal breast cancer patientsFontein, D. B. / Houtsma, D. / Hille, E. T. / Seynaeve, C. / Putter, H. / Meershoek-Klein Kranenbarg, E. / Guchelaar, H. J. / Gelderblom, H. / Dirix, L. Y. / Paridaens, R. et al. | 2012
- 3098
-
Impact of transition from analog screening mammography to digital screening mammography on screening outcome in The Netherlands: a population-based studyNederend, J. / Duijm, L. E. / Louwman, M. W. / Groenewoud, J. H. / Donkers-van Rossum, A. B. / Voogd, A. C. et al. | 2012
- 3104
-
Phase II study of bevacizumab with liposomal doxorubicin for patients with platinum- and taxane-resistant ovarian cancerVerschraegen, C. F. / Czok, S. / Muller, C. Y. / Boyd, L. / Lee, S. J. / Rutledge, T. / Blank, S. / Pothuri, B. / Eberhardt, S. / Muggia, F. et al. | 2012
- 3110
-
Sex moderates circadian chemotherapy effects on survival of patients with metastatic colorectal cancer: a meta-analysisGiacchetti, S. / Dugue, P. A. / Innominato, P. F. / Bjarnason, G. A. / Focan, C. / Garufi, C. / Tumolo, S. / Coudert, B. / Iacobelli, S. / Smaaland, R. et al. | 2012
- 3116
-
Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patientsArgyriou, A. A. / Velasco, R. / Briani, C. / Cavaletti, G. / Bruna, J. / Alberti, P. / Cacciavillani, M. / Lonardi, S. / Santos, C. / Cortinovis, D. et al. | 2012
- 3123
-
HIPEC in T4a colon cancer: a defendable treatment to improve oncologic outcome?Hompes, D. / Tiek, J. / Wolthuis, A. / Fieuws, S. / Penninckx, F. / Van Cutsem, E. / DHoore, A. et al. | 2012
- 3129
-
Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomasMimae, T. / Tsuta, K. / Kondo, T. / Nitta, H. / Grogan, T. M. / Okada, M. / Asamura, H. / Tsuda, H. et al. | 2012